Izoniazid in the Treatment of Schizophrenia by Simpson, R. Wallace






INFORMATION TO ALL USERS 
The quality of this reproduction is dependent upon the quality of the copy submitted.
In the unlikely event that the author did not send a com p le te  manuscript 
and there are missing pages, these will be noted. Also, if material had to be removed,
a note will indicate the deletion.
uest
ProQuest 13838859
Published by ProQuest LLC(2019). Copyright of the Dissertation is held by the Author.
All rights reserved.
This work is protected against unauthorized copying under Title 17, United States C ode
Microform Edition © ProQuest LLC.
ProQuest LLC.
789 East Eisenhower Parkway 
P.O. Box 1346 
Ann Arbor, Ml 48106- 1346
Isoniazid in the Treatment 
of Schizophrenia
Page
1. Introduction ... ...    1
2. Historical Section ..................  8
3. Insulin and Convulsive Treatments ... 28
4. Isoniazid Treatment ... ...... . ... 65
5. Discussion............   107
6. Summary and Conclusions .............  116
7* Bibliography ........................ 119
INTRODUCTION
Schizophrenia is one of the gravest diseases
affecting mankind. Ellery writes that it claims more
victims than either cancer or tuberculosis. In the
United States of America, each year 30,000 - 40,000
young people succumb to it, and he adds that in
proportion Australia is similar for at least one
quarter of the patients admitted to mental hospitals
are suffering from Schizophrenia.^^ It affects the
young before the majority have even reached the prime
of life and most of these young adults spend the best
part of their lives in institutions. The worst
sufferers come to lead what is almost a vegetative
existence. Skottowe’s findings, in an investigation
of 949 consecutive unselected admissions of psychotic
patients to the Buckinghamshire Mental Hospital in the
five year period 1936 - 1940 drawn from a population
of 309,600 persons, show that 94 men and 87 women were
suffering from Schizophrenia. These represented 22.5$
of the male admissions and 16.3$ of the female
admissions. 90$ of all the patients were under 40 
( 39)years of age.  ̂ ' In view of its chronic nature, the 
majority of the mental hospital population consists 
of schizophrenics - Henderson and Gillespie estimate 
the figure at 50$ to 60$.
It is doubtful whether any other illness causes 
so much human distress or entails so much unproductive 
expense. This economic side to the problem is also 
vast. The cost to the State of maintaining a patient 
in Knowle Hospital is £4. 1. Id per week. There is in 
addition the loss of the victim’s earning capacity 
and, in many cases, further expense to the State in 
assisting to maintain his dependents. A study in 
Massachusetts some years ago showed that ten cents of 
every State-tax dollar went for the care of 
schizophrenics.
It is generally agreed that spontaneous 
remissions do occur particularly in the early stages 
of the illness. However, it is very difficult to 
assess the extent of this remission. Ellery finds 
that the figures vary from 2$ to 39$, and adds that 
many of the remissions in the higher claims are 
temporary or of short duration. He quotes Muller as 
believing the figure for spontaneous remissions to be 
between 15$ and 20$, but he comments that Muller 
gives no indication as to what percentage of these 
may be permanent or what percentage may be complete. 
Smith states categorically that spontaneous recovery 
in Schizophrenia occurs in less than 10$ of cases.(^0)
In a condition like Schizophrenia in which the 
aetiology and the abnormal physiological and
pathological factors - if any - are unknown, any 
treatment must he empirical. Many organic treatments 
were tried in their turn hut all failed. In the 
beginning of this century some workers attributed the 
cause to focal sepsis and recommended operations on 
tonsils, teeth and other possible sources of 
infection, but such procedures were eventually proved 
to be of no value. Treatment with various vaccines, 
autovaccines and sera of recovered schizophrenics 
proved unsuccessful. An aseptic meningitis produced 
by means of horse serum introduced into the 
subarachnoid space was tried by Carroll. Various 
glandular products have been used but all with 
unpromising results.
The first real progress in organic treatment 
of mental illness was made following the clinical 
observations of recoveries of mental patients during 
intercurrent infections. This led to various fever- 
producing methods. The production of a sterile 
abcess with turpentine oil was especially used in 
France, while in other European countries the 
sulphosin method of Schroeder was widely applied in 
Schizophrenia. In 1917, Wagner-Jauregg introduced 
malarial treatment in general paresis, the first 
successful treatment of a mental illness on a purely
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organic basis. However, the use of malaria and of 
typhoid fever, and later of heat-producing agents of 
a physical nature, failed in Schizophrenia.
In 1922 continuous sleep treatment with
barbiturates was developed by £l'4si. Results in
Schizophrenia were poor. It is moreover a dangerous
therapy, carrying a high mortality rate. Sargant and
Slater comment, "Continuous narcosis is a symptomatic
method of treatment appropriate with certain syndromes
and on certain occasions. It is fundamentally an
interim procedure from which permanent benefits can
only be expected if the natural powers of recuperation
will be sufficient to bring about recovery, given a
( 37)breathing space of a fortnight or so."w  ' However, 
it can be considered as the most important predecessor 
of the so called "shock treatments" and many 
authorities consider that their modes of action are 
similar.
Hypoglycaemic coma treatment with insulin in 
Schizophrenia was introduced by Sakel in 1933* Since 
then, a great deal has been learned about the 
treatment but the basic technique employed by Sakel 
is the one still most commonly used. Although 
statistics vary greatly, it is generally accepted 
that insulin coma therapy is a valuable adjunct in
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the treatment of Schizophrenia. This is endorsed by 
the fact that in the twenty years since its inception 
it has become the most widely used treatment 
throughout the world for this illness. In 1935 von 
Meduna reported on his treatment of Schizophrenia by 
epileptic convulsions artificially induced by 
cardiazol. He claimed a most impressive remission 
rate especially for cases treated in the early stages 
of the illness. However, although it has proved a 
valuable treatment, von Meduna’s high claim of success 
in Schizophrenia has not been borne out by subsequent 
findings. The beneficial effect of hypoglycaemic 
convulsions in insulin treatment led G-eorgi to 
recommend combined insulin-convulsive treatment. Time 
and experience have proved that, although not 
necessary in every case, this combined treatment is 
very valuable in certain cases resistant to insulin 
treatment alone, and in other selected cases. In 
1938, Gerletti and Bini demonstrated, in Rome, the 
use of an electric current passed through the brain 
as a method of inducing convulsions. Its development 
followed extensive experimental work in electrically 
induced seizures in animals. This method has now 
largely replaced pharmocological convulsive treatment.
These new methods, while having their 
limitations, have introduced a little light into the
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dark recesses of the treatment of Schizophrenia and 
have given some hope for sufferers from this illness 
to he able possibly to lead comparatively normal 
lives.
From 1947 - 1952 as a specialist in psychiatry 
in the Royal Navy, I was in charge of the psychotic 
ward. In this time I treated 115 Schizophrenic 
patients with deep insulin coma therapy. The 
immediate results were very good but all these 
patients were young physically fit men, struck down 
before having reached even the prime of life. On the 
completion of treatment they were all automatically 
invalided from the Service, the careers of their 
choice being ruined. Since coming to Knowle Hospital 
as Assistant Psychiatrist in 1952, I have been in 
charge of the insulin unit and have treated more than 
40 cases suffering from Schizophrenia with this 
treatment. My impression is that a large number of 
the now chronic hospital population have, at one time, 
received insulin coma therapy which has failed, and 
that several admissions have previously had this 
treatment and have relapsed.
In a recent paper in the British Medical 
Journal on 1 The Effect of Isoniazid on Carbohydrate 
Metabolism in Controls and Diabetics", Luntz and Smith
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found that the administration of isoniazid produced
a temporary elevation of the blood-sugar level. They
showed that isoniazid itself, although a reducing
agent, was not responsible for the rise in blood-
sugar levels and therefore postulated that a
disturbance in carbohydrate metabolism could be 
(21)inferred.' J
My interest was aroused in the effect of using 
isoniazid in mental disorders, in particular in 
Schizophrenia, with the object in mind that it might 
possibly affect the metabolism of nerve cells. The 
food of nerve cells is carbohydrate and one of the 
theories for the beneficial effect of insulin and 
convulsive therapies is that they disturb the 
metabolism of the brain cells.
In the present thesis, the author proposes to 
give the results of his experience of the value of 
isoniazid in about sixty cases of Schizophrenia.
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HISTORICAL SECTION
Insulin was first used in psychiatry as a 
sedative in agitated states especially in delirium 
tremens and catatonic excitement, and it was also 
used to overcome refusal of food and to build up 
debilitated patients. However, the dosage in these
treatments was small. Haak did comment in 1929 that
he was surprised that a case of catatonic stupor could
be influenced by large doses of insulin. In 1928,
Sakel produced hypoglycaemic states to overcome the 
withdrawal symptoms in the treatment of morphia 
addiction, and he also used this method in the 
symptomatic treatment of psychotics. He noted that 
deeper hypoglycaemic states, occurring unintentionally, 
frequently had a beneficial effect on the psychosis 
itself. He therefore began to induce hypoglycaemic 
coma with insulin in the treatment of schizophrenia, 
and his first report on this work was presented in 
Yienna in 1933* His technique was soon being widely 
used throughout the world and it was introduced into 
this country in 1936 by Strecker. This original 
technique was so carefully and skilfully worked out 
that it is, apart from a few minor modifications, 
still the one most generally used. Sakel, in his 
1935 monograph on insulin treatment, warned against
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the danger of epileptic seizures occurring during 
hypoglycaemia, but he later fully recognised and 
stressed their therapeutic value, stating that 
hypoglycaemic shock may consist of either a coma or 
an epileptic seizure.
In 1935, von Meduna reported on his treatment 
of schizophrenia with artificially induced epileptic 
convulsions. He first used 25$ camphor in oil 
injected intramuscularly. The main disadvantages of 
this method were the impossibility of anticipating 
the time between the injection and the convulsion 
which could vary from 15 minutes to three hours, and 
the possibility that several convulsions might occur 
or none at all. Von Meduna therefore began to use a 
soluble synthetic camphor preparation, pentamethyl- 
entetrazol, known in this country as cardiazol and 
in the United States of America as metrazol. This is 
injected intravenously and was first used in a 20$ 
aqueous solution, but this strength often caused pain 
and thrombosis of the vein at the site of the injection 
on account of which it has since been used in a 10$ 
solution. This treatment was introduced into Great 
Britain in 1937 by L.C. Cook.
Combined insulin-cardiazol therapy was 
originally advocated by G-eorgi following his 
observations that a sudden improvement often resulted
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after a convulsion during hypoglycaemia. The 
endeavour to overcome the fear and anxiety associated 
with cardiazol and the belief that hypoglycaemia 
decreases the convulsive threshold for cardiazol were 
other reasons for the use of the combined treatment.
In the early years of this century various 
workers produced stupor, general anaesthesia, 
catatonic states and convulsions with an electric 
current. Cerletti and Bini first applied the method 
to individuals suffering from mental disease in 1937 
and reported on their findings in 1938. In an 
attempt to overcome the repellant prodromata of drug 
induced convulsions and the practical difficulty of 
repeated intravenous injections in patients with 
sluggish circulations, they began experimenting with 
animals and found that very large electric currents 
could be passed through the brain without producing 
histological signs of damage provided the exposures 
were not longer than about one second. Using an 
alternating current with a frequency of 50 cycles, 
they then applied the electrical method of inducing 
convulsions to human subjects, producing one thousand 
fits without accident. They obtained results at 
least as good as those claimed for the chemically 
induced convulsion therapies. Electric convulsive
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therapy is really a technical modification of 
pharmocological convulsive therapy which it has 
largely replaced.
SCHIZOPHRENIA
Towards the end of the last century, Kraepelin 
described a series of cases which arose mainly during 
the later years of adolescence and which, although 
differing in many individuals, possessed certain 
features in common. The chief of these were 
detachment from the outside world, incoherence of 
thought, impairment of judgment, loss of feeling and 
various peculiarities of behaviour. He found that 
the majority relapsed and ultimately passed into a 
state of permanent mental enfeeblement. He therefore 
named the condition Dementia Praecox. He 
differentiated three principal types which he termed 
hebephrenic, katatonic and paranoid. He later added 
a fourth variety described as simplex.
In 1911, Bleuler, approaching the condition 
from the psychological aspect, explained it as the 
result of a splitting of the intrapsychic life which 
did not necessarily end in dementia and which might 
arise in adult life. He therefore suggested the term 
Schizophrenia, and this has gradually superceded the
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older one of dementia praecox. Both Tredgold and
Ellery point out that the terms are not synonymous
and that while cases of dementia praecox evince the
schizophrenic type of reaction, all cases of
(4 )schizophrenia are not dementia praecox. '
(44) states that dementia praecox is always
followed by permanent mental deterioration. Although 
in some instances this process may undergo arrest, 
the patient is usually left on a definitely lower 
mental plane, while in many cases it gradually 
progresses to dementia.(44)
Practically all the symptoms occurring in 
mental illnesses may occur in schizophrenia, but 
certain symptoms are more pronounced and are common 
to all the varieties. Probably the most frequent 
symptom is failure of affect or emotional blunting 
showing itself in apathy and indifference. There is 
a lack of initiative, spontaneity and ambition. There 
results a progressive withdrawal from the outside 
world to an inner world of phantasy, and a consequent 
loss of active attention. The patient loses his 
pride in his personal appearance gradually becoming 
more untidy and slovenly. In many cases as the 
deterioration proceeds, his habits become faulty and 
degraded.
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Another important diagnostic symptom is 
emotional incongruity or disharmony between the mood 
and the thought. Happenings or situations in which 
the schizophrenic patient finds himself, which would 
normally have a profound emotional affect, produce 
only indifference or occasionally the opposite to the 
normally expected affect. Frequently there are 
sudden causeless outbursts of laughter or a silly 
vacant grin in which there is no real mirth. The 
schizophrenic’s laughter is not infectious as is the 
manic's. Many of these patients have delusions 
which are accompanied by a completely inappropriate 
emotional tone.
Schizophrenic thinking is said to be autistic 
and katathymic, that is, it is introverted with 
little or no attempt to transfer thoughts into real 
tangible acts and it is directed along the lines 
determined by some complex. It is often obvious that 
the schizophrenic patient is experiencing considerable 
difficulty in thinking and occasionally the stream 
of thought is completely interrupted for no obvious 
reason (thought blockage). Speech may be stilted, 
stereotyped, affected or childish. It may be 
incongruous and frequently shows irrelevancies; 
neologisms or words of the patient's own making are
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occasionally present. It may consist of a stream of 
words unrelated in meaning but rhyming or similar in 
sound, or in a mere meaningless incoherent jumble. 
Writing often shows similar features and large amounts 
of rubbish are frequently composed.
Ideas of reference, illusions, hallucinations 
and delusions constitute another group of symptoms. 
Ideas of reference are especially common. The patient 
is more sensitive and suspicious than normal and 
consequently believes that people are looking at him 
and speaking about him behind his back. Less 
frequently, this develops into the delusion that 
articles in the newspapers or topics on the wireless 
have special reference to him. Illusions I have not 
found to be common. Auditory hallucinations occur 
frequently. Sometimes the voices say pleasant things 
to the patient but more often they revile or accuse 
him. For a time they may not exercise much influence 
apart from his speaking back to them and the fact that 
he can sometimes be seen in a listening attitude, but 
often they dominate the patient and he acts in 
response to their suggestions and commands, frequently 
in a violent and impulsive way. Hallucinations of 
vision, smell, taste and touch are much less common 
than those of hearing. Delusions occur frequently ,
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and although it is said that the striking thing 
about them is their changeable and transient nature, 
I have not found this to be the case. In my 
experience, the schizophrenic patient often retains 
the same delusional beliefs for long periods and 
even indefinitely. However, they are very poorly 
systematized and are not accompanied by an 
appropriate emotional tone. Delusions of influence 
are very common. The patient believes that his 
thoughts are being read or that his mind and his 
actions are being controlled or influenced by some 
telepathic or hypnotic process, or by wireless or 
electricity. One case considered he was being 
controlled by cosmic radiation and therefore feared 
that he might be instrumental in setting off an 
atomic chain reaction.
The schizophrenic patient shows impaired 
judgment and a lack of proper appreciation of his 
position. In the majority of cases there is no 
insight or it is only very limited. The patient has 
no realization that he is ill and requires care and 
treatment, and he will give various reasons for his 
being in hospital such as that he was kidnapped and 
is being improperly detained, or that he just came 
along for admission because someone suggested it.
In the early stages of the illness these
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symptoms occur in a setting of relative clearness. 
There is no real clouding of consciousness. It is 
said that there is no disorientation hut I frequently 
find imperfect orientation to time which I consider 
due to the general apathy and indifference. The same 
reason accounts for the fact that the patient is 
often able to give only a poor account of himself and 
events leading up to his admission although his 
memory is usually good both for recent and remote 
events. The general intellectual faculties are 
unimpaired and there remains a good grasp of school 
and general knowledge. It is only later that, in 
many cases, a progressive mental deterioration sets 
in leading to a profound dementia.
Schizophrenia Simplex 
The chief features of this type are an 
insidious onset with a gradual blunting of feeling 
and conation but without, as a rule, hallucinations, 
delusions or any great incoherence of thought. It 
frequently occurs in the "shut in", reserved 
schizoid personality when it is merely an accent­
uation of the existing personality defects. The 
onset is usually soon after puberty and rarely later 
than the twentieth year. The patient becomes 
increasingly dreamy, detached and asocial. He shows
-  17 -
little interest, spontaneity or ambition, and is 
quite content to remain in a sheltered hospital 
environment being incapable of making any concrete 
plans for his future. He will often do simple 
routine work. Emotional blunting and apathy are 
usually marked. Memory and grasp of school and 
general knowledge are usually well retained, and 
evidence of gross dementia does not set in until the 
lapse of many years.
Hebephrenic Type 
The onset of this type is usually in the later 
years of adolescence. The main distinguishing 
feature is a marked emotional disturbance. There are 
sudden periods of wild excitement with impulsive, 
violent and often destructive conduct. Equally 
sudden periods of acute depression and tearfulness 
are liable to occur. Hallucinations of hearing and 
of sight are common and are usually vivid. Delusions 
are, as a rule, changeable and bizarre. Delusions of 
influence and ideas of reference are frequent. Great 
incoherence in speech is a prominent feature. The 
course tends to be gradually progressive. Habits 
become faulty and the general mental deterioration 
leads to dementia.
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Katatonic Type 
This type tends to occur first between the 
ages of twenty and thirty years. The onset is 
frequently said to be acute but closer investigation 
will usually reveal a history that, for some time, 
the patient has been vague, dreamy, apathetic and 
disinterested, with periods of odd, eccentric 
behaviour. Then, with very little warning, he passes 
into a state of dull stupor. If this is complete, 
there is mutism, refusal of food, and he sits slumped 
in a chair in one position for prolonged periods or 
he lies curled up in bed. He is insensitive to 
painful stimuli. There is either incontinence or 
retention or urine and faeces. He has to be dressed 
and undressed. He usually has to be tube-fed as food, 
placed in the mouth, is generally not swallowed. He 
may assume strange, statuesque postures which are 
maintained for long periods. Flexibilitas cerea is 
common. If the stupor is less marked, the patient 
may perform a series of stereotyped actions or he may 
show a marked degree of negativism or automatic 
obedience. Perserveration is common. Mannerisms may 
occur. In this state of stupor the patient 
understands what is going on around him but his 
apathy is so great that he takes no part in it.
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Suddenly the picture may change. The patient 
begins to take notice of things, to reply to 
questions, and to make spontaneous remarks. He can 
often give a full account of what has happened 
during his period of stupor. He gradually returns to 
a condition of apparent normality.
The second characteristic feature of this type 
consists of sudden periods of wild excitement with 
great impulsiveness. The patient may, without 
warning, suddenly become extremely violent and 
destructive, and actively homicidal or suicidal.
These actions may be in response to hallucinatory 
commands but are not necessarily so. This state of 
impulsive excitement may last from a few hours to 
days or weeks, and then suddenly subside.
Kraepelin reserves the name Katatonia for 
cases in which there is the conjunction of this 
peculiar wild excitement alternating with katatonic 
stupor, but, in my experience, it is now common to 
meet cases in which only the katatonic stupor occurs.
The katatonic type is usually characterised 
by remissions and recurrences, the majority of 
patients eventually passing into a state of chronic 
semi-stupor or chronic excitement, ultimately 
becoming demented.
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Paranoid Type 
This type tends to develop later in life than 
the other forms. It rarely arises before thirty 
years and may begin after forty years of age. The 
characteristic features are delusions, hallucinations 
and ideas of reference. The delusions are multiple, 
unsystematised and usually fantastic and illogical.
They are said to be changeable but I frequently find 
the same delusions retained for prolonged periods.
They may be of persecution, grandeur, depression, or 
of influence. The most notable feature is the lack 
of emotional tone concerning them and the marked 
incongruity between the delusional belief and 
behaviour which allows, for instance, the man claiming 
high titles and degrees to perform menial tasks in 
the ward. The hallucinations are usually aural and 
the voices are frequently annoying, accusing or 
threatening. These patients also show the general 
schizophrenic symptoms of incoherence of thought, 
detachment and withdrawal from reality with impaired 
judgment and insight.
Prior to the onset of this type, many patients 
have shown no gross mental abnormality and have good 
school and work records. At the beginning there may 
be short remissions and relapses but the general 
course is a gradual deterioration to eventual dementia.
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Aetiology
There are two main schools of thought in the 
controversial question of the causation of schizo­
phrenia. One group considers that the defect is 
primarily psychological and the other that it is 
essentially organic.
Adolph Meyer considered that the disease is
due to a failure in adaptation of the individual to
the stresses of life. He believed that it occurs in 
the schizoid personality whose characteristics are 
hypersensitiveness, instability, poor initiative, 
lack of aggressiveness, and a tendency to daydream 
and to seek refuge in evasions rather than face the
difficulties of life. In such a person, any
environmental stress against which he cannot contend 
may result in a withdrawal from reality and the 
symptoms of schizophrenia. Hoch and Jung have each 
expressed similar views.
The organic viewpoint has been put forward by 
various authors and mainly concerns theories of 
abnormality in the functioning of the brain cells or 
the.endocrine glands. Kraepelin believed that 
dementia praecox was due to auto-intoxication from 
a disordered secretion of the sex glands which acted 
on the brain cells. Mott supported this view. He
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found post-mortem changes in the cortical nerve cells 
which he considered were indicative of either 
suppressed or diminished function and evidence of a 
diminution of the oxidation processes. He also 
described evidence of a disordered action in the whole 
endocrine system with particular reference to the 
gonads, adrenal medulla and pituitary gland. He 
claimed that, in the majority of schizophrenics, there 
was a complete arrest of spermatogenesis with 
regressive atrophy of the cells of the testicular 
tubules, and, in female patients, he described changes 
in the ovaries. Lewis claimed that schizophrenics 
suffer from a state of aplasia of the circulatory 
system and an atrophy of the sex glands, and Gibbs 
reported that a large number of his cases had abnormal 
hair distribution and hair texture. A recent research 
in which biopsy specimens were taken from the testes 
of schizophrenics, supported Mott's findings. However, 
Mott's claims were disproved by Morse's investigations 
and by subsequent workers, and it is now generally 
held that, it has not yet been proved that there is 
any specific cellular pathology in the brain in 
schizophrenia and that, while the evidence of frequent 
abnormal endocrine function is very suggestive, no 
definite causal relationship between the abnormal
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function and schizophrenia has been proved.
Hereditary predisposition does play a part.
Only 3 - 5$ of the siblings and parents of 
schizophrenic patients have an outright schizophrenic 
illness, but the liability to the illness is 14-*7$ in 
dizygotic twins and 85.8$ in monozygotic twins.
Kallmann reports that the predisposition to 
schizophrenia, that is, the ability to respond to 
certain stimuli with a schizophrenic type of reaction, 
depends on the presence of a specific genetic factor 
which is probably recessive and autosomal.^
Hill states that the natural periodic short 
remissions and post-mortem findings seem to show that 
the brain cells are neither destroyed nor even harmed, 
but are deprived of some substance which is necessary 
for their function. In the remission, for some reason, 
the capillary walls suddenly become more permeable to 
the substance necessary for the functional activity of 
the brain cells.
Stockings considers that schizophrenia is a 
manifestation of a single organic cerebral disorder 
consisting of a profound derangement of the oxygen- 
glucose metabolism of the brain cells which affects 
principally the centres concerned with the higher 
thought processes, affective and intellectual functions.
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This condition, at first reversible, may if long 
continued lead to permanent cerebral damage. He 
further postulates a "dysoxic" or oxygen disordered 
type and a "dysglycolytic" or glucose disordered 
type.^41^
Many believe that schizophrenia is due to a
functional disorder in the hypothalamic region.
Morrow quotes the work of Finkelman and Stephens who
found that schizophrenics averaged a heat loss of
0.8°F. during exposure to cold compared with a loss
of 0.2°F. in controls, and that the normal reactive
hyperaemia of the skin after exposure was missing in
schizophrenic patients. They pointed out the
similarity of these findings to those seen in animals
with hypothalamic lesions and therefore suggested a
physiological disturbance in that region in 
(2 1 )schizophrenia.v '' Hoskins states that Ransom
believed that the secret to the causation of the
illness was most likely to be found in the
hypothalamus and cites the work of Brookhart and his
collaborators of the Ransom's Institute. They showed
that, by hypothalamic puncture, it was possible to
eliminate sexual behaviour and hence reproductive
capacity from guinea pigs of both sexes while the
reproductive apparatus, endocrine and otherwise,
(1 1 )remained microscopically normal.v
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Hoskins, in a summary of the abnormal 
biological findings in schizophrenia, stresses the 
following points:-
1. A relative deficiency of catalytic iron has been 
found. He regards this as of special importance in 
view of the various evidence of deficient oxygen 
uptake in the psychoses. He further stresses the 
importance of all the catalytic systems of the body 
and states that almost any symptomatology in 
schizophrenia might be accounted for by defects in the 
enzyme systems.
2. His own uncompleted studies point towards rather 
marked deficits in the tissue vitamin stores and he 
underlines the important role played by the vitamins 
in the enzyme systems of the body.
3. He emphasises the influence of the various amino- 
acids on cell processes and functions. In some of the 
lower organisms, the maturing processes and those 
leading to cell specialization are determined by 
d-glutamic acid and 1-proline. As immaturity is an 
outstanding feature of schizophrenia, he considers that 
the immaturity, and hence the psychosis itself, might 
ultimately prove to be fundamentally due to an 
aberration in amino-acid metabolism.
4. He mentions the evidence of endocrine deficiencies
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in schizophrenia and states that the defect is not 
necessarily one of levels of hormone production but 
might be due to inadequate reactivity to the hormones. 
He considers that the hormone defect might be the 
basis for the schizophrenic immaturity and gives in 
support of this theory the evidence that thyroid 
deficiency can hold an organism, such as the tadpole, 
in an immature state of development for long periods, 
that early deprivation of the pituitary prevents 
maturation, and that the sex hormone has an important 
influence on the maturation of an adult behaviour 
pattern in puppies.
Hoskins concludes that schizophrenia represents
an end result of a generalised failure of adaptation
that arises from defective evolution of the maturity
processes, and that the accessory symptoms can be
regarded as constituting secondary adaptations to the
difficulties arising out of the primary defect. As
an alternative theory, he states that the psychosis
itself or the postulated immaturity may be due to a
specific pathology which might exist in abnormalities
of one or more enzyme systems of the brain, in an
aberrant amino-acid metabolism or in a disorder in
(1})the hypothalamic region. '
Finally it can be mentioned that schizophrenia 
may be due to a disorder in glucose metabolism in the
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brain resulting in the production of a toxic 
breakdown substance akin to mescaline or lysergic 
acid.
The wide divergence of these various theories 
on the aetiology of schizophrenia and the absence of 
any positive evidence towards a definite pathology, 
brings home our lack of knowledge on the disease and 
emphasises the difficulty of the whole problem. This 
is especially apparent in the field of treatment and 
it accounts for the numerous empirical methods which 
have been tried, the majority with but limited 
success.
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INSULIN COMA TREATMENT AND CONVULSION THERAPY 
INSULIN COMA TREATMENT
Technique
Soluble insulin is injected intramuscularly at 
7.0 a.m. each morning from Mondays to Fridays. 
Saturdays and Sundays are rest days. The patient has 
had no food since supper on the previous evening. The 
commencing dose of insulin is 20 units, which is 
increased on subsequent days by 20 units until coma 
occurs. If the dosage reaches 200 units without 
producing coma, the method of "swinging" is used to 
overcome the insulin resistance. The dose is dropped 
to the initial dose, the next day 100 units is given, 
and on the third day 200 units. This procedure is 
repeated for several days and if a coma is not 
produced the patient is given an electrically induced 
convulsion whilst in hypoglycaemia in an attempt to 
break down the follovring day's insulin resistance.
By these methods it is seldom necessary now to exceed 
200 units to induce coma, whereas previously I often 
had to continue the increase to 400 units or more.
The initial coma dose is kept constant for one week 
and is then reduced by 10 units daily until the
minimum satisfactory coma dose has been found. This 
is maintained for seven to ten treatments after which
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the dose is again diminished by 10 units to see if 
any further reductions are possible in the minimum 
coma dose. I find that, in the majority of patients, 
insulin sensitivity increases during treatment, and, 
if this method of reducing the dosage is neglected, 
the danger of irreversible comas is much increased.
The treatment room must be kept at a warm, 
even temperature as the patients perspire profusely. 
Beds supplied with removable padded sides are used.
The patient's temperature, pulse and respiration rate 
are taken before the insulin is injected, and again 
in the evenings. The pulse and respiration rates are 
recorded half hourly during treatment. On this daily 
treatment chart are also shown the onset and amount 
of sweating, the patient's colour, restlessness, 
state of consciousness, the onset of sopor and coma, 
and remarks on general behaviour and neurological and 
other abnormalities in sopor and coma. The insulin 
dosage and amount of glucose necessary for interruption 
are included on this chart. In addition to this 
individual record, a general treatment chart is kept 
which contains the names of all the patients under 
treatment, the times of onset of sopor and coma, the 
time when each patient is due to be interrupted, the 
actual time of interruption and the time of his
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awakening. Finally an insulin dosage book is 
necessary for entering the following day's dose of 
insulin.
There is much difference of opinion about the 
use of the word "coma". Some workers use it to mean 
loss of consciousness and others say it is not present 
until the corneal reflex has disappeared and the 
plantars show an extensor response. I have used the 
criteria of coma given by Kuppers as reported by 
Sargant and Slater. He differentiates the stages of 
loss of consciousness into sopor or precoma and true 
coma. The onset of sopor is indicated by the loss of 
a normal response to speech and impairment of 
orientation. Responses are confused. The onset of 
coma is shown by the loss of all purposive responses 
even on careful testing. There are no responses from 
visual, auditory or tactile stimuli. Painful stimuli 
may produce some movements but these are not directed 
towards removing the stimulus. Tests should include 
raising and dropping the patient's arm, passing a hand 
quickly before his eyes, and pressure on the supra 
orbital nerve.^^
If no sopor has occurred by 10 a.m. hypo- 
glycaemia is terminated by giving the patient one and 
a half pints of 33•1/3$ sugared tea to drink. Sopor
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is allowed to continue for one and a half hours 
"before being interrupted if no coma supervenes.
When the patient begins to go into coma, the coma is 
increased from five minutes on the first day to ten 
minutes on the second, twenty minutes on the third, 
and then thirty minutes on subsequent days. In sopor 
and coma, interruption is carried out by a nasal tube. 
After withdrawing gastric juice and testing for 
acidity with litmus paper to ensure that the tube is 
in the stomach, a pint and a half of warmed 33*1/3$ 
glucose solution is poured in. If the patient is not 
awake twenty minutes after the usual feed, intravenous 
33*1/3$ glucose is given. 40 ccs is generally 
sufficient to rouse the patient. As soon as possible 
after awakening, the patient has a breakfast of high 
caloric value.
At the onset of coma an airway is inserted and 
before interruption, gr.1/100 of atropine is injected 
to facillitate absorption of the feed and diminish the 
risk of vomiting.
The following complications are taken as calling 
for an immediate intravenous interruption of treatment:-
1. Evidence of circulatory failure shown by cyanosis, 
poor peripheral circulation, a persistently 
irregular pulse, or a pulse rate of above 120 or 
below 50 in coma.
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2. Laryngeal stridor persisting after insertion of 
the air-way.
3. Evidence of respiratory distress.
4* Vomiting either before or after nasal interruption.
5. Epileptic fits occurring in coma or late sopor.
Pits in the earlier stages of hypoglycaemia 
indicate interruption by the oral or nasal method.
6. Persistent undue restless leading to exhaustion.
7* Waves of extensor tonus in coma in the presence of
a free air-passage.
8. Generalised tremor when the patient is not cold.
The most important and serious complication of 
insulin coma treatment is the occurrence of a prolonged 
or irreversible coma. It occurs most often when the 
hypoglycaemia is unduly prolonged or is allowed to 
become too deep. It is generally agreed that it is 
not simply a state of hypoglycaemia and various 
theories as to cause have been suggested such as acid­
osis, vascular impairment, hyperinsulinism, and 
exhaustion of the nerve cells which consequently are 
unable to utilize glucose even though there is an 
adequate amount of it present in the blood stream. 
Severe cases may involve days of unconsciousness, 
while, in milder ones, wakening is delayed until the 
late afternoon. Prompt treatment is essential and I 
adopt the following procedure. If a patient does not
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respond to the usual termination of the hypoglycaemia 
and does not waken within five to ten minutes after 
the injection of intravenous glucose, 100 ccs. of a 
33*1/3$ glucose solution is given intravenously and, 
if the patient does not show signs of awakening, the 
injection is continued up to 250 ccs. At the same 
time 2 ccs. of coramine is given. Hot water bottles 
are applied and a 5$ mixture of carbon dioxide in 
oxygen is used. Should the patient come out of coma 
and become restless and excited, gr.i of morphia and 
gr.l/100 of hyoscine is injected subcutaneously. If 
he remains in coma for an hour after the last 
injection, a further 250 ccs. of 33*1/3$ glucose 
solution is given intravenously, and then 500 ccs. of 
5$ glucose in saline is administered by a slow 
intravenous drip. At the same time a further gr.l/100 
of atropine is injected, the stomach contents are 
drawn off by a nasal tube and one and a half pints of 
33*1/3$ glucose solution is run into the stomach.
This procedure of intravenous glucose in saline, an 
injection of coramine and tube feeding is repeated 
every four hours until the patient is awake. If there 
is no response in twelve hours, blood transfusions are 
given.
The doctor should be present in the insulin 
treatment unit throughout the period of coma and
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awakening. Before coma, one nurse is necessary for 
every three patients and during coma one nurse for 
every two patients. It is best to have the same team 
throughout treatment, and it is most important that 
the sister or nurse in charge should be highly trained 
and experienced in this work.
Treatment is continued for fifty to sixty comas 
although, if it is going to be successful, an 
improvement is usually apparent after the first few 
comas, or even before the coma stage is reached. The 
benefit at first may only occur for an hour or two 
after treatment, gradually becoming longer until the 
improvement is maintained. A prominent feature is a 
marked improvement in rapport, sociability and 
friendliness occurring after wakening, and advantage 
should be taken of this for general supportive 
psychotherapeutic measures.
Psychotherapy, indeed, is a most important 
adjunct to the treatment and many workers maintain 
that it is more beneficial than the actual chemical 
effects of the insulin. It should include repeated 
explanations and reassurances, a discussion of the 
patient’s problems in a general broad way, and when 
the time comes for his discharge from hospital 
assistance and advice on his rehabilitation and fears
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about facing the outside world. The treatment 
situation is actually a type of group psychotherapy, 
and there is a strong feeling of comradeship and 
sympathy among the patients undergoing the treatment. 
Advantage should be taken of this. In the afternoons 
and evenings arrangements are made for them to take 
part in occupational therapy, to go on walks and 
other outings, and to participate in social functions 
as a group. They should be in charge of a nurse who 
carries a supply of glucose tablets and who is 
experienced in detecting the early signs of hypo­
glycaemia.
The most important contra-indications to 
insulin coma therapy are cardio-vascular disease, 
active pulmonary tuberculosis, diseases of the kidneys, 
liver, pancreas, thyroid or adrenal glands and 
diabetes.
Variations in Technique.
Sakel varies his terminations according to 
different psychotic manifestations of schizophrenia.
In the paranoid forms he uses the classical deep coma 
method. For stuporose catatonic patients, the insulin 
dose is raised until an activation of the stupor is 
achieved. This usually occurs in the phase of building 
up to the coma dosage. At this stage the hypoglycaemia
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is terminated. After the stupor is broken through, 
the patient receives the usual coma treatment. 
Patients showing catatonic excitement are given only 
sufficient insulin to quieten them and hypoglycaemia 
is terminated before they reach a coma dosage. It 
is, however, generally agreed that these rules for 
termination have not been sufficiently established, 
and I agree with the majority of other workers that 
states of catatonic stupor and excitement are best 
treated by convulsive therapy before or during 
insulin coma treatment.
Insulin, according to Sakel's original method, 
is given six times a week with one rest day. This 
procedure is followed by many therapists. Sargant 
and Slater give full treatment on five days, half 
doses of insulin on the sixth day and a rest day on 
the seventh.w  '
There is some controversy over the ideal 
duration of treatment, but most workers apply fifty 
to sixty comas before discontinuing insulin. The 
majority of patients who are going to respond show 
signs of improvement early in the treatment, often 
before coma dosage is reached, but even in these cases 
who recover after a few comas it is wiser to continue 
until a full course of 50 comas has been given as one 
feels that this lessens the danger of a relapse.
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Experiments have been made in the intravenous 
use of insulin but it is generally agreed that this 
has no great advantage over the intramuscular 
technique. In addition, it has been found that 
patients develop late shock more readily, that 
allergic reactions occur more frequently and convulsions 
more often in coma with intravenous insulin. With 
patients who are very restless and excited in the early 
stages of hypoglycaemia it is, however, useful to give 
the insulin in divided dosage, one injection intra­
muscularly at 7 a.m. and the other intravenously one 
to two hours later.
Kraulis favours the protracted form of coma 
treatment, prolonging a state of deep coma for twelve 
hours and upwards, at the same time feeding small 
amounts of sugar either two hourly by a nasal tube or 
by a continuous intravenous drip of 5$ glucose in 
saline. However, the majority are opposed to this 
method mainly on account of its increased mortality 
rate and because of the danger of permanent brain 
damage.
Hill gives small doses of insulin and histamine 
and claims that his percentage of successes is about 
the same as with insulin shock therapy and even that 
his technique has far more effect in chronic cases
-  -
( 12 )than insulin. However, his series of cases is
very small and his findings have .not received 
subsequent support.
CONVULSION THERAPY
Various machines are available for electro- 
convulsive therapy (ECT) but all are based essentially 
on Bini’s original design. Alternating current from 
electric light circuits having a frequency of 50 
cycles is used. A volt meter regulates the voltage 
to be applied and most machines have a time measure 
graded in fractions of a second. The original apparatus 
had a second low-voltage current circuit for preliminary 
measurement of the resistance of the patient’s head, 
but this has now been dispensed with as it has been 
found that there is no true correlation between the 
resistance reading and the convulsion threshold.
Most operators adjust the setting beginning 
with, for example, 100 volts for 0.2 seconds until a 
satisfactory convulsion dose is reached. I give 130 
volts for one second with all co-operative patients, 
as this produces a fit in almost every instance 
thereby cutting out the unpleasantness of an abortive 
response. I also consider that this dosage diminishes 
the risk of fracture. Where the patient is 
particularly tense or actively resistive, I use a
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smaller dose sufficient to induce a stun which 
ensures relaxation and I then follow it with the 
convulsion dosage.
Cardiazol (pentamethylentetrazol) is injected
intravenously as rapidly as possible in a 10$
solution using a wide bore needle. The initial dose
is 3-5 ccs. If no convulsion results within one
minute, another dose 1 cc. greater than the original
dose is immediately given. If this also fails to
evoke a seizure, the dosage is increased by 1 cc. on
the following morning, and so on until a satisfactory
convulsive dosage is found. The fatal dose is between
25 and 30 c c s . ^ ^  In Neustatter's opinion, the
maximum dose should not be above 12-15 ccs. depending
( )on the weight of the patient. '
The preparation and the control of the patient 
during the fit is the same with both EOT and Cardiazol 
induced seizures. No food is given for three hours. 
Before treatment the patient receives an injection of 
gr. 1/100 of atropine and he empties his bladder and, 
if necessary, his bowels. Dentures, spectacles, 
hairpins and other metal objects should be removed.
The clothing is loosened. A rubber gag covered with 
lint is inserted in the mouth to prevent tongue biting. 
The patient lies on a firm surface such as a hard
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mattress with a hoard underneath it - I use a 
stretcher trolley which has a metal top covered by 
a thin mattress -, a firm pillow is placed in the 
small of the back and a small pillow underneath the 
head. With ECT, the electrodes are covered by pads 
of lint and these are soaked in 30$ saline. The 
temples are cleaned and left moist with a strong 
saline in spirit solution immediately before the 
electrodes are applied. In order to prevent fractures 
and dislocations, the technique of holding the patient 
during the seizure is of the utmost importance. On no 
account must undue force be applied. A nurse at the 
head holds the mouth gag in place and the patient’s 
chin firmly on the gag. This prevents a possible 
dislocation of the jaw. The arms should be held into 
the sides, a nurse's hands being placed round the 
deltoids so as to hold the shoulders in. The legs 
should be straight, lightly held together at the 
ankles, but once the convulsion starts no force should 
be used either to prevent the extension of the legs or 
to counteract the clonic movements.
With EOT the response is immediate. There may 
be a subshock of "stun" with a momentary loss of 
consciousness and possibly a degree of cyanosis for a 
few seconds; or an abortive fit or petit mal; or a
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major convulsion of a typically epileptic type with 
a tonic phase lasting approximately ten seconds and 
a clonic phase lasting about thirty seconds. This is 
followed by a period of coma of short duration from 
which the patient awakens confused and drowsy. This 
state lasts from five to thirty or more minutes.
With cardiazol, the convulsion occurs three to thirty 
seconds after the injection during which time the 
patient does not lose consciousness, and he experiences 
an extremely unpleasant sensation of fear and anxiety. 
He becomes pale and rigid, and makes a few clonic 
movements following which there is a cry, opening of 
the mouth, loss of consciousness and then a tonic 
spasm of the whole musculature for about ten seconds. 
This is followed by the clonic part of the convulsion, 
lasting forty to forty-five seconds. The paroxysm 
ends with a period of apnoea with marked cyanosis for 
several seconds, and this passes into a comatose sleep 
of five to ten minutes’ duration. There is then a 
period of confusion lasting half an hour or longer.
If no convulsion takes place with cardiazol, the 
patient often experiences great discomfort, anxiety 
and restlessness which may continue for several hours.
With ECT there is subsequent amnesia for the 
convulsion and also for a varying time prior to the
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treatment. When cardiazol is used, the patient has
an amnesia for the fit hut, unfortunately, he
remembers the deadly fear which he experienced
between injection and convulsion. This, and the
unpleasant discomfort when no fit results, are the
most unpleasant features of cardiazol treatment and
they frequently lead to the patient's refusal to
continue therapy. They are among the most valid
reasons for the superiority of the electric method of
(17)producing therapeutic convulsions. {/
Other advantages of ECT over cardiazol are
(15)summarised by Jessner and Ryanv 7 as follows:-
1. There is rarely prolonged psychomotor excitement
as sometimes occurs after the cardiazol convulsion, 
and no vomiting.
2. There is no difficulty with veins. Cardiazol 
readily produces thrombosis at the site of the 
injection.
3. The fit is less violent with ECT and the degree 
and frequency of cardiac complications are much 
less.
4. Economy.
5. ECT can be used for outpatient treatment.
Shepley and McGregor found that cases which 
previously failed to respond to cardiazol equally
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showed no response to ECT, and that cases previously- 
showing response to cardiazol equally appeared to 
respond to ECT.^-^ It would therefore seem that, 
therapeutically, cardiazol has no advantages over ECT 
and, on account of the drawbacks mentioned above, it 
has now been largely supplanted by the latter 
treatment.
The frequency and duration of convulsive
treatment depends largely on the psychiatric condition.
I consider that Sargant and Slater are too conservative
( ~\1 )about the spacing of treatment. J I agree with 
Kalinowsky and Hoch that two or three convulsions a 
day should be given to acutely disturbed patients who
(17)are threatened by the danger of psychotic exhaustion.v " 
I give stuporose cases treatment daily until they 
respond. Depressive illnesses usually only require 
two convulsions weekly. In other conditions it is 
generally necessary to apply treatment three times a 
week. However, I am of the opinion that it is better 
to avoid confusional states, and, if these are 
produced, ECT should be spaced at a longer interval 
for that patient. Many workers realized early that a 
frequent reason for the failure of convulsive therapy 
in schizophrenia was the premature discontinuation of 
treatment because of the disappearance of all
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psychotic symptoms after a few convulsions.
Kalinowsky and Hoch quote G-erhardt as having found
that the reinstitution of treatment after a relapse
did not lead to the same favourable results as a
long uninterrupted course of treatment, and Erohn as
showing that the majority of his relapses belonged
to the group of remissions after treatment of short 
(17)duration. In schizophrenia, it is therefore
necessary to continue until twenty to thirty 
convulsions have been given even although the patient 
appears well after the first few treatments.
The complications of convulsive therapy are 
remarkably few. The most frequent are fractures and 
dislocations (1.1$ incidence), particularly compressed 
fractures of the thoracic vertebrae, the great 
majority of which are not serious and necessitate 
little in the way of treatment. Memory defects are 
common and are usually slight and transient. Extreme 
depression of the respiratory centre sometimes occurs 
and calls for prolonged artificial respiration. Other 
complications have been reported but are extremely 
rare.
Contra-indications may be summarised as acute 
bodily diseases, chronic diseases of the heart, blood 
vessels, lungs or kidneys, diseases of bones or joints,
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exophthalmic goitre and patients who have been 
confined to bed for more than one year. Practically 
all these can be overcome by giving treatment modified 
with scoline, the technique of which is as follows:- 
The patient is prepared in the usual way. An 
injection of 5$ sodium pentothal calculated by the 
formula Body Weight in lbs. _ is then given
10 x 3
intravenously immediately followed by scoline
Body Weight in lbs.  injected through the same100 x 2 ccs*
needle. The lungs are then inflated with oxygen for 
about a minute and the convulsion is then induced.
It consists of gentle muscular twitchings. Afterwards, 
the lungs are again inflated with oxygen until normal 
breathing is reinstituted. Scoline is succinylcholine 
chloride dehydrate, a synthetic muscle relaxant of 
short action. It produces a paralysis lasting from 
two to six minutes. Very occasionally recovery from 
scoline is delayed and it is then necessary to apply 
gentle artificial respiration until the paralysis 
passes off. It has to be used sparingly in patients 
suffering from liver disease and malnutrition. With 
scoline-modified treatment, there are few contra­
indications to EOT.
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COMBINED TREATMENT
A combination of insulin coma treatment and 
convulsive therapy can be given in many ways. A 
course of ECT may be followed by insulin treatment 
or vice versa, convulsions may be administered on 
insulin rest days or they may be given during the 
various stages of hypoglycaemia. In the latter 
instance, I give ECT after the patient has been in 
coma for fifteen to twenty minutes, and immediately 
follow it with the intravenous method of interruption. 
Some other workers, however, prefer to administer 
convulsive therapy in the early stages of hypo­
glycaemia. I think it is important that one does not 
confine oneself rigidly to any of these methods. They 
are all of value and whichever one is used depends on 
the individual patient.
SELECTION OF CASES AND RESULTS
Insulin coma treatment was introduced for the 
cure of schizophrenia, and it is for this illness that 
it is now used. Experience has shown that certain 
cases are unlikely to respond and, in view of the 
limited facilities for applying this treatment, it is 
important that the most favourable cases should be 
selected. All workers are agreed that the duration of
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the illness is of primary importance, that the best
prognosis occurs when the duration is less than
eighteen months, and that practically no remissions
can be expected when it is over three years. Strecker
found a complete and incomplete remission rate of
about 60$ in the first year, 30$ in the second year
and that, in the third and subsequent years, the
percentage was again progressively halved. (42)
Stockings, using insulin coma therapy and ECT for
schizophrenia in the Army, where the cases are nearly
all of recent and acute onset, claimed a complete
remission rate of 70$, a definite improvement in 15$,
and failure in 15$.^"^ Garmany’s results are 
(8)similar. ' My own findings during seven years of 
Naval psychiatry support this. For obvious reasons 
early signs of mental abnormality much more readily 
come to notice than in civilian life. Of 112 cases 
of schizophrenia which I treated with insulin coma - 
some with ECT in addition - less than 10$ had to be 
certified and transferred to civilian mental hospitals, 
while over 90$ became well enough to be invalided from 
the Service to their own homes. Of course this only 
refers to immediate results. Due to various 
difficulties, the main one being that these homes were 
scattered widely over the whole country, it was
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impossible to carry out a follow-up study on the 
patients. I felt that several on leaving hospital 
would relapse, but even one of the worst of those had 
remained well and usefully employed, earning a good 
wage five years after being invalided from the Navy.
A stable pre-psychotic personality is next in
favour of a good prognosis. An open and socially
well-adjusted person reacts better than one who has
always been shy, introspective and odd. Another
helpful feature is a sudden onset to the illness as
this brings the condition sooner to attention and to
treatment. Unfortunately, however, it often turns
out that the so called sudden onset is merely an
exacerbation of a more insidious process. Sargant
and Slater quote Freudenberg's findings that the body
physique is of some importance and that the pykni« or
athletic habitus is more favourable than the asthenic
or the dysplastic.  ̂ Schizophrenic illnesses in
which there are definite precipitating factors are
said to have a good outlook.
(q )G-ralnick believes that the type of 
schizophrenia is not a significant factor but most 
workers consider that it is of some importance, 
although opinions differ. Stockings thinks that
the simple type is probably, from the beginning, an
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example of a purely degenerative form of brain
disease and most are agreed that this type has the
worst prognosis. My own view is that the other three
types should be given the benefit of insulin treatment
if possible, depending, when selection is necessary,
on the other prognostic factors mainly on the duration
of the illness. It is generally agreed that the
paranoid form shows the best response but Kalinowsky
and Hoch quote Muller as stressing that this is only
(17)if it is treated in the first year of the illness. ' 
Strecker states that catatonic excitement is more 
responsive to insulin while catatonic stupor does 
better with convulsive therapy. I agree with
Kalinowsky and Hoch that the combined insulin and 
convulsive treatment should be used in the stuporose 
catatonic patients, and I consider that this method 
should also be used in cases of catatonic excitement. 
Stockings^^ writes that hebephrenics do well with 
insulin if it is given early enough. This is 
contrary to the general opinion which is that the 
prognosis in this type is poor.
Mayer G-ross gives a good summary for the 
indications for using the combined method of treatment.
1. Preparative - to achieve the co-operation of 
resistive, negativistic, restless, excited and
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stuporose patients and those who refuse food or 
eat inadequately.
2. Provocative - to break down insulin resistive 
patients.
3. For combating affective admixtures of the 
schizophrenic clinical picture; depression, 
listlessness, drowsiness, general moodiness, 
manic features.
4. For speeding up recovery in those patients who, 
after initial improvement, remain on the same 
level for three to four weeks without further 
progress. (^3)
The early claims for the success of insulin 
coma treatment were very high. Mason Smith in 1937 
wrote that reports of European clinics showed that 
75$ of patients ill less than six months were 
completely recovered as a result of the treatment, 
and that more than 69$ of those ill less than one and 
a half years became productive, socialised individuals 
able to resume w o r k . ^ ^  Ellery in 1937 quoted 
Muller's Swiss figures as 76$ full remissions if the 
illness was under six months' duration, and 68$ if 
the illness was under eighteen m o n t h s . T h e  results 
collected by the British Psychiatric Insulin Society 
and quoted by James, Freudenberg and Cannon in 1938
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showed a complete and social remission of 86% where
the illness was less than six months, and of 79%
where it was less than eighteen months. More
careful follow-up studies have not supported these
findings. Gralnick writes that insulin is of
definite value but by no means as effective as early
(Q)enthusiastic reports led one to believe. ' Mayer 
Gross states that most workers agree with Muller who 
now reports that, in patients whose illness has 
lasted not longer than one year, the numbers of 
remissions in schizophrenia can be doubled. He adds 
that insulin coma treatment neither provokes nor 
prevents relapses and that the remissions after it
are neither shorter nor longer than spontaneous
(2^) (7 )remissions. Finiefs’s' ' ' findings with a
thousand cases of schizophrenia were as follows
1 . 446 patients received no special treatment. 34.5% 
discharged with an average stay in hospital of
8.3 months.
5 years and over. Of those discharged, 40% kept 
well and 40% relapsed
2. 82 patients given convulsive therapy - 39% dis­
charged.
3. 103 patients given the combined method - 54.3%
discharged.
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4. 378 patients given insulin coma therapy - 54.2%
discharged, with an average stay in hospital of 
5 months.
5 years and over. Of those discharged 62% kept 
well, 30% relapsed.
Bond and Shirley write that of 309 schizo­
phrenic patients treated over a ten year period,
48.8% were recovered or much improved at the end of 
treatment, 43% at the end of the first year, and 
37% at the end of five years. This compares with a 
recovery-much improved rate of 16% for control cases 
under hospital treatment without insulin or other 
sho ck tre atment. ̂
The mortality for insulin coma treatment is 
less than 1%.
Electro-convulsive therapy is undisputedly the 
treatment of choice for depressive and manic illnesses. 
There can he no doubt that it is extremely valuable as 
a symptomatic maintenance treatment in chronic 
schizophrenia, and it has revolutionalised the 
atmosphere of the chronic mental hospital ward. No 
longer does one see the groups of catatonic patients 
standing in bizarre attitudes or slumped in a semi- 
stuporose condition in chairs. It has almost 
abolished the need for prolonged tube feeding and for
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restraint. It has diminished the burden of the
nursing staff almost beyond belief.
The use of convulsive therapy alone as a
treatment in early schizophrenia is much more
controversial. Again the extravagant results of the
earlier workers have not been substantiated. Von
Meduna claimed a remission rate of 80% in early cases
before the onset of permanent symptoms of mental
deterioration. Jessner and Ryan quote Von Meduna's
later figures when, with Friedman, he surveyed 3,000
cases of schizophrenia of under eighteen month's
duration treated with cardiazol convulsive therapy
which produced a remission rate of 52%, and a great
improvement in an additional 20%. They add that these
figures have been supported by other workers and cite
Kennedy as saying that there seems little doubt that
convulsion therapy has given considerably better
results than the spontaneous remission rate for
comparable case material. Jessner and Ryan conclude,
however, that in schizophrenia it is not so effective 
(15)as insulin.v 1 Mayer Gross considers that 
convulsive therapy cannot equal the results of insulin
as to completeness and permanency of recovery in
(2^) ( 12) schizophrenia. 1 Rees is of the same o p i n i o n . '
Cook, in the early days of the treatment, pointed out
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that, if therapy was interrupted before completion,
relapse was common. His view was that the remission
rate for both convulsion and insulin coma treatments
was at least twice as great as that to be expected
from spontaneous remission and that, in addition,
recovery was more r a p i d . M o r e  recently Fergus
writes that ECT is definitely less satisfactory and
relapses are more frequent when an insufficient
number of treatments is given. With overactive,
disturbed and markedly regressed patients, he gives
three treatments on the first day, two on the second,
one on the third and then three a week. Others are
given three a week from the start. The majority
receive three a week to at least thirty treatments.
If there is marked organic confusion, treatment is
(6)immediately reduced. ' Worti.s states that, if EOT 
is used in schizophrenia, the consensus of opinion 
is that treatment must be prolonged and intensive 
with at least sixteen to twenty treatments.
Kalinowsky and Hoch hold similar views. They remark 
that even although the question of whether insulin 
or EOT is superior in schizophrenia remains undecided 
in view of contrary statements and lack of comparative 
studies, the value of EOT in this condition is 
sufficiently answered. They quote Cook's survey of
all opinions and conclusions that between 55$ and 
60$ of patients treated with convulsions in the 
first year of their illness may be expected to remit 
sufficiently to take their former place in society. 
Another group of workers consider that insulin is not 
sufficient as a sole form of treatment in schizo­
phrenia. They found that ECT was effective in 15$ of 
patients who failed to respond to insulin coma and 
that insulin coma was effective in 17$ who failed to 
respond to E C T . ^ ^
In 1938, Strecker concluded a paper as follows 
“The results obtained with insulin and with convulsive 
therapy in the first years of illness show that they 
constitute a decided advance in the treatment of 
schizophrenia. It would be a mistake to neglect 
either method or to practise one to the exclusion of 
the other. Little more can be added to this
statement today. Although neither treatment nor both 
is a specific for schizophrenia, it can, I feel, now 
be considered proved that they give results much 
better than could be expected for spontaneous 
remissions.
THEORIES AS TO MODE QE ACTION 
It is not known how insulin and the convulsion 
treatments exert their beneficial effect. No one 
theory has found universal acceptance, and it is only
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possible to mention a few of the numerous suggestions 
that have been made. It is, however, generally agreed 
that both treatments have a similar mode of action.
Some workers believe that the somatic part of
the treatment is only incidental and that the effect
on the patient is essentially psychotherapeutic.
Kalinowsky and Hoch quote Meier’s view that the main
effect is due to the more intimate contacts between
the patient and the doctor and nurses, and Schatner's
opinion that with the patient helpless and dependent,
the physician becomes a mother surrogate, the patient
establishes a better transference and therefore
(17)becomes more therapeutically approachable. 1 I do 
not consider that one's general findings support this. 
With EOT, the patient requires little attention and 
outpatient treatment has given particularly good 
results in certain cases. Other methods of treatment, 
in which the patient receives much care, have not 
given similar good results.
Schilder and other workers stress the importance 
of the feeling of impending death, victory over it and 
the sensation of rebirth in all shock t r e a t m e n t s . ^ ^ 5 )  
Bychowski believes that, in psychotic patients, there 
is a struggle between the repressed normal ego and its 
pathological substitute and that hypoglycaemia
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eliminates the pathological ego and its counter 
cathexis, thereby allowing the repressed ego and its
(  o )repressed (or denied) reality to enter their rights. '
However, a conscious feeling of impending death is, in
the opinion of most investigators, an uncommon feature
of insulin coma and electro-convulsive therapies and,
if these theories were valid, one would expect similar
good results with such procedures as continuous sleep
treatment and anaesthesia. Bychowski does not explain
how hypoglycaemia eliminates the pathological ego.
Kalinowsky and Hoch ask why it is that all the
mediaeval tortures inflicted on the insane failed to
produce impressive therapeutic results, especially
when they were inflicted on a conscious person in whom
the so-called emotional shock or death threat must
(17)have been much more intense.v '
Others consider that the patient regards the 
treatment as a punishment administered by the doctor 
who is a father figure and that, after treatment which 
expiates his sins and sense of guilt, he can resume 
his normal position in life. But the majority of 
patients do not regard their treatment as a punishment 
or as anything fearsome, and this theory again does 
not explain why insulin and convulsive therapies 
should succeed where other types of treatment, such as
-  58 -
fever therapy and sleep treatment and the mediaeval 
tortures and punishments, failed.
Von Meduna1s theoretical basis for the 
introduction of convulsive therapy that schizophrenia 
and epilepsy were antagonistic to each other has not 
received subsequent support, and evidence has, in 
fact, disproved it.
It has been suggested that these treatments act 
by destroying brain tissue and this view has received 
some support from the more recent successes of pre- 
frontal leucotomy in some cases of schizophrenia. But 
it has not been proved that histological damage 
results from insulin or convulsive therapies unless a 
prolonged coma has occurred, and clinically the 
treatments do not cause any permanent intellectual 
deterioration. Kalinowsky and Hoch mention Stief's 
theory that both forms of therapy produce spasms in 
the cerebral capillaries which eliminate diseased 
nerve cells, thereby bringing about the desired 
therapeutic results. They rightly point out the main 
objection to this view as the fact that in schizo­
phrenia it has not been conclusively shown that there
(17)is histological evidence of any brain cell defect. J 
Hill's opinion is that the abnormal cerebral 
function in schizophrenia is due to a pathological 
barrier to the normal passage of plasma situated in
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the endothelial cells of the capillaries. He
considers that insulin acts hy liberating histamine
which makes the endothelial cells of the capillaries
more permeable to normal plasma, thus enabling the
nerve cells once more to obtain the substances
(12)requisite for their normal function.v ' His claims 
for the success of his treatment with small doses of 
insulin and histamine have not, however, been 
supported.
The effects of insulin and convulsive treatments 
have been attributed to cerebral anoxaemia, longer 
lasting in the former and of short duration in the 
latter. Some believe that this has a sedative effect 
and allows the brain to restart a normal rhythm of 
activity, while others believe that the benefit is due 
to a compensatory overactivity which follows on the 
period of anoxaemia. There is a further view that the 
anoxaemia causes a reflex stimulation of the 
sympathetic system. Changes in oxidation have been 
demonstrated during and after shock treatments, but 
if this was the entire answer to the cause of the 
improvement one would expect beneficial results from 
methods which simply limit the oxygen consumption to 
the schizophrenic patient, and this has not been 
found to be the case.
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The food of the brain is carbohydrate, and on 
its metabolism depends cerebral function. There is 
no doubt that insulin coma treatment profoundly 
disturbs carbohydrate metabolism which is also upset 
to a lesser extent by convulsive therapy. Numerous 
investigators consider that this disturbance results 
in a stimulation of the metabolism of the central 
nervous system with a consequent improvement in 
function. The mechanisms of this stimulation is more 
difficult to explain. A high carbohydrate diet or the 
giving of large amounts of sugar either parentally or 
intravenously has no effect in schizophrenia. Parfitt 
remarks that findings suggest that the sugar level is 
controlled by hypothalamic centres.(^0) Probably the 
majority opinion at the present day is that the 
benefits of both insulin and convulsive therapies are 
due to their effects on diencephalic mechanisms.
Rapid changes in weight, sleep, appetite and the 
menstrual cycle are produced and changes in water 
metabolism and autonomic function have been demonstrated. 
Harris writes that it is well known that cardiazol and 
electro-convulsive therapy cause anterior pituitary 
secretion in rabbits, probably by exciting some part 
of the h y p o t h a l a m u s . R e i s s  states that ECT 
apparently stimulates the production of all the 
hormones from the anterior pituitary, and the final
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endocrinological change is a resultant of the 
antagonisms between the different quantities of 
hormones mobilised.(43b) Various workers stress 
different anterior pituitary hormones as playing the 
most important part in the therapeutic effect.
Wortis quotes G-ellhorn's view that all shock treat­
ments operate by stimulating the hypothalamic - 
sympathetic - adrenal system. In the case of insulin, 
the hypothalamic stimulation is a release phenomenon; 
in convulsive therapy, direct stimulation is 
involved.^47) Robie also believes that ECT acts 
directly upon the pituitary gland and, via electro­
chemical processes, a change is produced in pituitary 
biochemistry resulting naturally in changes in the 
thyroids, adrenals, gonads and other glands of 
internal secretion, these changes being presumably 
tonic in n a t u r e . O t h e r  investigators, including 
those of the Pavlov Institute, consider that the 
common factor of these treatments is the production 
of cortical inhibition coupled with subcortical 
release or vegetative mobilisation. However, it has 
not been proved that schizophrenia is due to an 
abnormal vegetative regulation or to an abnormally 
functioning hormone. The clinical evidence of the 
altered autonomic activity such as improvements in
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sleep, appetite, weight and circulation may well he 
due to the improved mental condition resulting from 
the treatment rather than the actual cause of the 
improvement.
Kalinowsky and Hoch quote the opinions of
G-eorgi, Demole and Freudenberg who hold that
alterations of the nerve cell membrane are responsible
for the success of these therapies. Evidence of this
membrane alteration is found in a reduction in the
amount of sugar in the cell which is produced slowly
in the hypoglycaemic state and quickly with cardiazol
(17)and electric shock. ' Others believe that the 
benefit is due to a compensatory increased metabolism 
which follows this reduction of the sugar content.
Wortis suggests that ECT probably effects a 
redistribution of brain acetylcholine. He states that 
most known convulsants, including ECT, insulin hypo- 
glycaemia and carbon dioxide promote acetylcholine 
production, and most anti-eonvulsants inhibit i t . ^ ^  
In a later paper, he comments that the frontal cortex 
of the chronic deteriorated schizophrenic seems to 
contain too much cholinesterase.  ̂ If these views 
were substantiated, they would be of considerable 
importance. Treatment of mental illness by acetyl­
choline injections, however, has given disappointing 
results.
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I consider that the line of investigation 
mentioned by Weil-Malherbe may be far reaching. He 
quotes the observations of Colowick, Cori and Slein 
on the inhibition of hexokinase by a pituitary factor 
and reversal of this inhibition by insulin. He 
himself has found substances in blood plasma which 
influence the activity of brain hexokinase in the 
direction of either inhibition or activation and, as 
the appearance of these substances is clearly 
correlated with the phases of carbohydrate assimilation , 
he assumes that they are of hormonal origin. Different 
groups of patients were found to show different 
patterns in response to a metabolic stress such as a 
glucose test dose. Patients suffering from schizo­
phrenia of several years* duration often showed a flat 
glucose tolerance curve and a low fasting blood sugar, 
and were characterised by the absence of either 
inhibitors or activators of hexokinase in their blood 
plasma after the glucose test dose.^'^c^
I feel that the functional mental illnesses may 
well be due t.o a defect in cerebral metabolism due to 
a fault in one or more of the enzyme systems. Whether 
a schizophrenic or a manic-depressive picture results 
would depend partly on the genetic constitution and 
partly on which enzyme systems were involved and the
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level of the breakdown in metabolism. Insulin coma 
treatment and convulsive therapy could exert their 
beneficial action by an effect on the faulty enzyme 
thereby bringing the metabolism closer to normal.
This action could be direct but is more likely to be 
mediated through an hypothalamic-pituitary mechanism.
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ISONIAZID IN SCHIZOPHRENIA
Isoniazid is a new anti-tubercular drug. Its 
full name is isonicotinic acid hydrazide and it has 
the following structural formula:-
It is a white, crystalline solid, freely soluble in 
water at any pH.
Rubin and co-workers reported on the 
pharmacology of isoniazid in mice, rats and dogs.
They found that it was rapidly absorbed after oral 
administration to mice and dogs. Approximately 
sixteen hours were required for the disappearance of 
the drug from the circulating plasma of dogs. Acute 
toxicity in mice and dogs was characterized by 
excitement and convulsions which were delayed in 
onset even after intravenous administration. Sub­
acute toxicity in rats was evidenced by anorexia, 
loss in body weight, occasional convulsions and 
slight hepatic damage. Chronic administration to 
dogs resulted in anorexia, loss in body weight, 
ataxia, tonic and clonic,convulsions, fatty degener­
ation of the liver and•jaundice. Reversibility of 
these effects appeared possible upon prompt cessation 
of drug administration.^^
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Elmendorf and co—workers reported on studies
of the administration of isoniazid to tuberculous
patients. In man, the drug was promptly absorbed.
After a single oral dose of 3 mgms. per Kgm. of body
weight, the maximum concentration in the plasma
(0.13 to 0.34 mgm. per cent.) was attained after one
hour. A high percentage was excreted in the urine
during the twenty-four-hour period after ingestion.
The drug was also excreted in the saliva and the
faeces. Appreciable concentrations of isoniazid
were present in the cerebrospinal fluid within three
hours of an oral dose of 2.0 to 3*0 mgm. per Kgm. in
patients without meningitis. The administration of
the drug for periods of four to sixteen weeks on
3.0 mgm. per Kgm. daily dose was not associated with
any manifestations of drug toxicity in any of the
patients studied. With patients on this dosage,
there was no evidence of accumulation. Isoniazid
possesses a high degree of activity against M. tuber-
(5)culosis in animals and in the body fluids of man.
A preliminary report on a large scale clinical 
investigation of isoniazid by the Medical Research 
Council^suggested that isoniazid was a very 
effective drug in pulmonary tuberculosis, but that 
when given alone it was not more effective than
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combined streptomycin and paramino salicylic acid
(P.A.S.). Bacillary resistance to isoniazid was
found in 71% of cases at the end of the third month
of treatment. Lack of progress could be related to
the emergence of resistance. A second report to the
(2^)Medical Research Council studied the effects of 
various combinations of isoniazid, streptomycin and 
P.A.S. in the treatment of pulmonary tuberculosis.
It showed that when isoniazid was combined with 
streptomycin, bacillary resistance to isoniazid at 
the end of the third month was reduced to 13%* It 
was concluded that, over a three month period, 
streptomycin 1 gm. daily and isoniazid 200 mgms. 
daily was clinically the most effective anti- 
tuberculous chemotherapy yet investigated, although 
its superiority to streptomycin 1 gm. daily and 
P.A.S. 20 gm. daily was not great. Streptomycin + 
isoniazid compared with isoniazid alone over a three 
month period was found to be considerably more 
effective in lowering the sedimentation rate, in 
suppressing tubercle bacilli in the sputum and also 
in improving the radiographic appearances. It was 
slightly more effective in resolving pyrexia. The 
two treatments produced equally striking improvements 
in the general clinical condition and in weight.
Other workers stated that their patients reported a
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sense of well-being when on isoniazid. A further 
report of the Medical Research Council showed that 
isoniazid + P.A.S. was a powerful addition to the 
acceptable drug treatments of pulmonary tuberculosis 
over a three-month period.
Luntz and Smith state that isoniazid contains
in its molecule a hydrazine residue which provides
it with a two-fold action - a reducing action and the
property of combining with sugars to form hydrazones
and osazones. They quote Izume and Lewis as reporting
that hydrazine derivatives induce hypoglycaemia by
injuring the liver and thereby interfering with the
formation of liver glycogen. Luntz and Smith, from
their investigations, conclude that the administration
of isoniazid produces a temporary elevation of the
blood sugar level and makes both the rise and fall of
an oral glucose tolerance test slower. They show
that isoniazid itself, although a reducing agent, is
not responsible for the rise in blood sugar levels,
and therefore deduce that a disturbance in carbo-
(21)hydrate metabolism may be inferred.v '
In view of these findings, I decided to observe 
the effects on the mental state of schizophrenic 
patients to whom isoniazid was administered. These 
cases were quite unselected except that they were
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practically all of long standing, many of whom showed 
severe mental deterioration. The patients were from 
four different male wards in the hospital, one of 
which was the second refractory ward. Rimifon, the 
Roche preparation of isoniazid, was used in a dosage 
of 100 mgms.four times daily.
This study covers sixty cases of schizophrenia. 
In thirty-one, the drug was administered and its 
effect on the mental state assessed over a period of 
several weeks. In twenty-four cases, in addition to 
observing the effect on the mental condition, blood 
sugar estimations were carried out in the fasting 
condition and one, two and three hours after the 
ingestion of 100 gm. of glucose. This was done before 
commencing isoniazid therapy, one week after it was 
started and again three weeks later. In this group 
there were an additional five non-schizophrenic 
subjects. Finally, in five cases, blood sugar 
estimations were carried out in the fasting condition 
and then at half-hourly intervals to two and a half 
hours after the ingestion of 100 gm. of glucose in 
divided dosage by the Exton-Rose technique. This was 
done before isoniazid was started and again four and 
seven days later. On these days, the fasting 
cerebrospinal fluid sugar estimation was also done.
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This group contained one additional non-schizophrenic 
subject. The plasma levels of isoniazid were not 
determined.
CASE 1
Age 24. Schizophrenia Hebephrenia. Admitted 27.2.53.
He was vague and detached from reality and 
unable to give an account of himself. His speech was 
slow and hesitant and showed evidence of thought 
blockage and confusion. He grinned and grimaced for 
no apparent reason. He was listless, apathetic and 
showed marked emotional blunting. He had no drive or 
initiative. He was untidy. He was deluded, believing 
that he was accused of murder and he alleged that 
people slandered him. He had ideas of reference and 
of influence.
He had a history of abnormal psychopathic 
behaviour dating back for seven years.
Electro-convulsive therapy produced only a 
limited response. He became cleaner and tidier and 
showed more interest, but otherwise his condition 
remained as above.
Isoniazid was started on 2.4.53* and he soon 
began to show a marked improvement. He became much 
more alert in speech and manner and his conversation 
no longer was confused or showed evidence of thought
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blockage. He showed much more initiative, drive and 
spontaneity, and worked well in the ward. There was 
no obvious delusional system, and he lost his ideas 
of reference, persecution and influence. He remained, 
however, rather suspicious in attitude, emotionally 
blunted, and was unable to give an account of events 
leading up to his admission to hospital.
Isonaizid was stopped on 9*7.53. His 
improvement was maintained, and he was discharged to 
the care of his relatives on 30.9.53* His plans for 
the future were very vague and he lacked insight.
It was considered that he had made a partial remission 
and that a future relapse was probable.
He gained 15 lbs. in weight while the drug was 
being administered.
This case was assessed as ’'improved1' as a 
result of treatment.
CASE 2
Age 37. Schizophrenia Paranoia. Admitted 23.10.46.
He was morose, suspicious, solitary and 
asocial. He was manneristic, vague and detached.
His answers to questions were often irrelevant and he 
could give but little account of himself. He was 
subject to auditory hallucinations, and was frequently 
noisy and violent in response to them. He had various
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changeable delusions, and constantly believed that 
the wireless used a repetition of peoples' names 
combined with disgraceful language in order to make 
people stupid.
He had always been "irritable and apt to lose 
his temper". His illness began in 1945 when he was 
serving with the Army in India. He showed no 
response to insulin coma therapy and to two courses 
of ECT.
A prefrontal leucotomy on 9•5 * 53• relieved the 
aggressive and impulsively violent features, but he 
remained dull, lacking in initiative and spontaneity, 
untidy and slovenly, and hallucinated. He could give 
no account of himself.
Isoniazid was started on 8.10.53* He soon 
began to improve and when the drug was stopped on 
12.12,53* he kept himself clean and tidy and showed 
some initiative and a little spontaneity. He worked 
in the ward on simple tasks under supervision, and he 
wrote letters home. He answered questions rationally, 
but his conversation was very limited and he could 
give no account of himself. He was no longer 
obviously hallucinated.
Some time after isoniazid was stopped he began 
to regress slowly becoming untidy and slovenly and 
completely devoid of initiative. He stopped working
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in the ward and writing letters home.
He gained 1 lb. in weight while the drug was 
being administered.
This case was assessed as ’improved” as a 
result of treatment.
CASE 3
Age 37. Schizophrenia Simplex. Admitted 2.5.52.
He was dull, vague, apathetic, detached and 
disinterested. He was solitary and asocial. He had 
vague ideas of reference and persecution. He was in 
a state of perplexity and stared dully in front of 
him, being unable to give any account of himself. He 
was capable only of the simplest routine tasks in the 
ward under direct supervision.
He was reported to have always been a shy, 
asocial person with a poor work record. He stayed at 
home for three years after the war, and in that time 
rarely spoke. He was previously a patient in this 
hospital, for five months in 1951. He showed only a 
temporary response to EGT.
Isoniazid was started on 26.2.53* He soon 
became much brighter, less lethargic, and showed much 
more initiative and spontaneity in speech and action. 
His work improved and he could be trusted to work 
without supervision. He took more interest in his 
surroundings and in his personal appearance, and he
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began to mix with the other patients. He lost his 
perplexity and answered questions rationally and 
coherently. He became less blunted emotionally and 
smiled much more readily. His visitors commented 
on the improvement.
The drug was stopped on 22.4.53. and, for 
several months, he maintained his improvement. He 
then began to revert to his former state of dis­
interested apathy. He again became solitary and 
asocial with marked emotional blunting, and would 
only do a little work under close supervision.
He gained 4 lbs. in weight while isoniazid was 
being administered.
This case was assessed as ’'improved” as a 
result of treatment.
CASE 4
Age 50. Schizophrenia Catatonia. Admitted 1.4.49.
He was simple, childish and fatuous. His 
conversation was limited and often irrelevant. He 
had delusions of influence, believing that he was 
controlled by atomic energy directed by ’’the power 
behind the throne”. He was aurally hallucinated, and 
had ideas of reference and of persecution. He showed 
marked emotional blunting. He was unoccupied and 
unemployable. He frequently became mute, inaccessible
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and catatonic, refusing food for long periods. These 
stuporose phases responded to EOT but it was 
occasionally necessary to resort to tube feeding.
His illness began in the U.S.A. in 1941. He 
was a patient in mental hospitals there from 3.2.42. 
to 24.12.42. and from 7.2.44. until he was deported 
and admitted to this hospital.
Isoniazid was started on 26.2.53. He became 
brighter and more alert and a useful and willing 
worker in the ward without supervision. He showed 
good initiative. His conversation was rational and 
coherent, and he spoke more freely. His ideas of 
reference and of persecution were less marked, and he 
no longer would admit to the delusions noted 
previously. The drug was stopped on 22.4.53* and he 
quickly deteriorated to the condition he was in 
before it was started. It was recommenced on 27.5.53. 
and he again became much brighter and more alert, and 
generally improved as when he was on the drug before. 
Isoniazid was stopped on 15.10.53* and this time the 
improvement was maintained apart from the fact that 
he did not converse so freely. He has not had a 
phase of catatonic stupor since being on this 
treatment, which is the longest period he has been 
free from one for several years.
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He lost 8 lbs. in weight while the drug was 
being administered.
This case was assessed as '’improved" as a 
result of treatment.
CASE 5
Age 36. Schizophrenia Hebephrenia. Admitted 11.3.42.
He was inaccessible and almost mute. He was 
detached, solitary and asocial. He was apathetic 
with no interest in his surroundings, unoccupied and 
unemployable. He was manneristic, keeping his face 
covered with his hands and not looking at anyone. At 
times he was very destructive especially to his clothes. 
He was slovenly and untidy. He was depressed and 
hypochondriacal. He frequently grinned and grimaced 
for no apparent reason. At times his habits were 
faulty. He had had nine courses of ECT, to each of 
which he made only a slight and very temporary 
response.
His illness began in 1937. He was a patient 
in this hospital from 8.2.38. to 13*9.38.
Isoniazid was started on 25.2.53* and stopped 
on 25.4.53. He had become brighter, more alert and 
spoke much more freely. He was, however, agitated 
and very hypochondriacal and he asked for further 
ECT. He was therefore given eight treatments between
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27.4.53. and 21.5.53* with little response, and by 
10.6.53* his condition had deteriorated almost to 
that as noted in the first paragraph. Isoniazid was 
again administered. Within a week he was brighter 
and more alert, speaking more freely and showing more 
initiative and spontaneity. Pie continued to improve, 
began working in the ward and, on asking for a job to 
occupy his mind, he was sent to the occupational 
therapy department where he worked diligently and 
quite well. He remained in this phase until 15.10.53. 
when the drug was stopped. Thereafter he regressed, 
becoming withdrawn, solitary, unoccupied and 
unemployable. He was very depressed and said he was 
being subjected to mental tortures. He again kept 
his face covered with his hands. Isoniazid was once 
more administered from 14.11.53. and he quickly 
improved as before. He returned to working in the 
ward and at occupational therapy. He was bright and 
cheerful and spoke freely. His habits were clean, 
and he kept himself clean and reasonably tidy. He was 
no longer destructive. He did not cover his face with 
his hands but was sociable and friendly, and took more 
interest in things in general. At one of the 
Christmas parties, I saw him participating with 
fervour and with a keen spirit of competition in all
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games, laughing, happy and obviously enjoying himself. 
The marked change was commented on by other medical 
officers who had known him previously. He remains on 
isoniazid and the improvement has been maintained.
He gained 7 lbs. in weight while the drug was 
being administered.
This patient was assessed as "improved" as a 
result of treatment.
CASE 6
Age 3 5 * Schizophrenia Hebephrenia. Admitted 18.11.52.
He was simple and childish in speech and 
behaviour. He was emotionally unstable and falsely 
elated. His conversation was vague and flippant. He 
had delusions of bodily dysfunction and of influence, 
believing that he was controlled by electricity 
operated by some person. He was subject to auditory 
hallucinations, admitting that he heard G-od's voice 
speaking to him daily. He was devoid of insight and 
stated he came into hospital to test a theory. His 
judgment and appreciation of his position were 
grossly impaired. He kept himself clean and tidy, 
he was co-operative and well behaved, and he worked 
on simple jobs in the ward. He mixed freely with the 
other patients, and participated in ward games and 
some social functions. He showed little response to
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a course of ECT.
He had a very poor family history. His illness 
began in 1940 and he was a patient in this hospital 
from 11.1.41. to 23.3.41., and from 13.8.45. to 
27.8.45.
Isonaizid was commenced on 2.4.53* He became 
very much worse. He was over-active, restless, 
confused, bewildered and manneristic. He was untidy 
and slovenly. He was no longer co-operative and he 
began to interfere with the other patients. He was 
unemployable and could not take part in ward games 
and social functions. He was fatuous and showed 
marked emotional incongruity.
Isonaizid was stopped on 19.5.53. and he 
became much steadier, reverting to his condition prior 
to treatment. He was quieter and again well behaved 
and co-operative. He kept himself clean and tidy. He 
worked in the ward, was no longer interfering and he 
mixed well with the other patients. He remained 
deluded and hallucinated, lacking in insight and in 
judgment, and was vague and flippant in speech.
He lost 3 lbs. in weight while the drug was 
being administered.
This patient was assessed to have "deteriorated"
as a result of treatment.
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CASE 7
Age 35. Schizophrenia Catatonia. Admitted 19.12.51.
He was completely mute and inaccessible, 
negativistic, resistive and unco-operative. He was 
asocial, disinterested, unoccupied and unemployable 
in the ward. He stood in one position or sat slumped 
in a chair for long periods in a typically catatonic 
manner. His attitude was uncertain, and he was 
occasionally impulsively violent probably in response 
to hallucinatory voices. He was untidy and slovenly 
in his dress and in his habits. He masturbated 
frequently and openly.
His illness began in 1946 and he was a patient 
in two mental hospitals from March to October 1947, 
responding to ECT. He was first admitted to this 
hospital on 31-3•49- when he was aggressive, violent, 
manneristic, restless, incoherent and hallucinated 
with many delusions of persecution. He responded well 
to a course of ECT being discharged on 11.8.49. 
However, he was re-admitted six weeks later after 
further violence. He made no response to deep insulin 
treatment and several courses of ECT. A prefrontal 
leucotomy was done on 2.6.51. after which he steadily 
improved until he was able to be discharged on 
31.10.51. when he showed no gross mental abnormality.
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However he soon relapsed and was re-admitted. His 
condition rapidly deteriorated to that noted in the 
previous paragraph.
Isoniazid was begun on 25.2.53. and he soon 
became more alert and active, responding quickly in 
his actions when spoken to. He no longer remained 
for long periods in catatonic postures. He stopped 
masturbating. He was still mute. Later he became 
tense and negativistic. The drug was stopped on 
22.4.53* following which he resumed open masturbation. 
He became very suspicious, uncertain and aggressive 
and his habits were faulty. Treatment was re-started 
on 19.6.53. and he soon became much brighter and more 
alert, co-operative and no longer negativistic. His 
habits were clean and he stopped masturbating. He 
remained mute and suspicious. Rimifon was stopped on
25.8.53. and he soon reverted to his former state.
It was again resumed on 20.10.53. and this time the 
improvement was even more marked. He began to speak 
freely and answered questions rationally, coherently 
and briskly. He was alert and co-operative, and it 
was possible to employ him usefully in the ward. He 
started to dress himself and to look after himself, 
and his habits were clean. He stopped masturbating.
He took more interest in things in general, and
-  82 -
played football for the patients1 team. He did, 
however, remain at times suspicious and uncertain in 
his attitude.
He gained 4 lbs. in weight while the drug was 
being adminstered.
This patient was assessed as "improved" as a 
result of treatment.
CASE 8
Age 38. Schizophrenia Hebephrenia. Admitted 28.11.41.
Chronic Mental Defective.
He was simple, childish, dull and retarded. He 
was emotionally facile and would often smile and laugh 
foolishly for no apparent reason. He could give no 
reliable account of himself. He was untidy, slovenly, 
and his habits were faulty. He was aurally hallucinated. 
He was unemployable, destructive and frequently 
impulsively aggressive. He required every nursing care 
and attention. He made only limited and temporary 
responses to ECT.
He was always feeble-minded and in 1936 he 
became unmanageable at home and was committed to a 
Mental Defective Colony for six months. In 1941 when 
serving in The Pioneer Corps he was admitted to a 
Military Hospital as he was unable to carry out his 
duties, and he required attention to see that he
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washed and dressed. He had a mental age of 9 years.
He began to show schizophrenic features and he was 
therefore transferred to this hospital on 28.11.41.
Isoniazid was started on 25.2.53* following 
which he improved considerably. He became quiet, 
co-operative and easy to manage. His habits were 
clean and he would dress himself, although he remained 
slovenly and untidy. He was no longer destructive or 
violent. He answered questions rationally. The drug 
was stopped on 22.4.53. and he soon deteriorated to 
his previous state. It was re-started on 17.6.53. and 
he again improved, becoming quiet, co-operative, clean 
and tidy, with clean habits. He lost his destructive 
and violent tendencies. Rimifon was stopped on
25.8.53. and once again he reverted to his former 
condition. It was resumed on 20.10.53. but, this time, 
after responding as before for six weeks, he began to 
deteriorate and when the drug was finally stopped on
16.12.53. his mental state was as described in the 
first paragraph. He subsequently showed no change.
He lost 2 lbs. in weight while the drug was 
being administered.
This case was assessed as "improved" with 
treatment as he initially responded well to it.
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CASE 9
Age 40. Schizophrenia Hebephrenia. Admitted 20.8.42.
He was dull, retarded, apathetic and almost 
devoid of initiative. His conversation was rambling 
and irrelevant, and his replies to simple questions 
were often contradictory. He was slovenly and untidy 
in his dress and habits. He exhibited various 
mannerisms and laughed in a fatuous way for no 
apparent reason. He was simple and childish. He 
expressed delusional ideas which were changeable and 
of brief duration. He had no insight and stated he 
came into hospital to look after the apple trees and 
the brick work. He had shown no response to a course 
of ECT given shortly after his admission.
He had a good, stable prepsychotic personality. 
His illness began in 1942 when he was serving in the 
Army from which he was invalided in June 1942, two 
months before his admission to this hospital.
Isoniazid was started on 25.2.53. He soon 
began to be very much tidier and took pride in his 
personal appearance. He developed a little initiative 
and worked in the ward under supervision. His 
conversation remained rambling and irrelevant. The 
drug was stopped on 22.4.53* and he maintained his 
improvement for four months, after which he gradually 
regressed to the state he was in before treatment.
-  85 -
Rimifon was re-administered from 15.10.53. and once 
again he soon improved. He became neat, clean and 
tidy, and took an obvious pride in his personal 
appearance. He worked well in the ward without 
supervision, following instructions although not 
showing much initiative on his own. He has played 
several good games of football for the patients' team. 
He was alert and no longer retarded. His mannerisms 
disappeared. He answered questions rationally 
although his conversation was limited. He enquired 
spontaneously whether he could have hospital leave.
He gained 2 lbs. in weight while the drug was 
being administered.
This patient was assessed as having "improved" 
as a result of treatment.
CASE 10
Age 56. Schizophrenia Hebephrenia. Admitted 22.7.27.
He was dull, retarded, simple and demented. He 
was apathetic and disinterested in his surroundings.
He mumbled continually to himself and, although 
answering simple questions rationally, his conversation 
was frequently incoherent and he could give no reliable 
account of himself. He said the year was 1930 and that 
he had been in hospital for three years. He was almost 
completely unoccupied. He was aurally hallucinated,
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but had not shown any impulsive or violent trends 
since 1930. He was inclined to be very occasionally 
noisy during the night.
He served in World War 1 and was "shell shocked" 
in 1917. It was reported that subsequently he was odd 
and peculiar being pre-occupied with his war 
experiences. The first florrid schizophrenic signs 
appeared in 1925 when he was away from work for nine 
months being very hallucinated. His illness recurred 
in March 1927 with auditory hallucinations, delusions 
of persecution and impulsive violence.
Isoniazid was started on 25.2.53* His condition 
soon deteriorated markedly. He became over-active, 
restless, interfering and very noisy. He was 
destructive, impulsive and violent. There was no 
change in his conversation. The drug was stopped on 
22.4.53* and he remained in this state for three months, 
after which he began to improve slowly to the condition 
he was in before treatment.
He lost 3 lbs. in weight while the drug was 
being administered.
This patient was considered to have "deteriorated" 
as a result of treatment.
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CASE 11
Age 41. Schizophrenia Catatonia. Admitted 4-7.52.
He was completely mute, negativistic and unco­
operative. He was detached from reality, apathetic, 
disinterested, solitary, asocial and unoccupied. His
attitude was inclined to be suspicious and uncertain.
He was always of a reserved, melancholy 
disposition. His illness began in 1951 in Canada, 
where he was admitted to a mental hospital for
treatment on 24.9*51. A diagnosis of catatonic
schizophrenia was made and he was deported in June 
1952, after which he was admitted to this hospital.
He showed no response to a course of ECT.
i
Isoniazid was begun on 26.2.53. Within a week 
he was brighter and answered questions rationally in 
monosyllables. He continued to improve becoming much 
brighter and more alert. He conversed rationally and 
freely, but only when spoken to. He had little 
spontaneity or initiative, but was more interested in 
his surroundings. He kept himself clean and tidy. He 
remained suspicious and negativistic in attitude.
When I asked him what the month was, he replied that 
I knew it as well as he did. He was, however, less
tense and anxious. The drug was stopped on 22.4.53. 
following which his conversation steadily dwindled
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and he became less alert and more sullen and 
disinterested. Treatment was recommenced on 10.6.53. 
after which he again spoke much more freely and he 
showed a little spontaneity. He was brighter and 
more alert, but unoccupied and unemployable. He was 
more interested in things in general and he began to 
read the daily papers. Rimifon was stopped on 
15.7-53- and after a few weeks he slowly returned to 
his previous state. He was completely mute, 
inaccessible and withdrawn. Isoniazid was restarted 
on 18.11.53. and again he improved as before. He 
was quiet, well behaved and much more co-operative, 
being less suspicious in attitude. He conversed 
rationally and coherently when approached. He 
remained asocial and unemployable.
He gained 10 lbs. in weight while the drug was 
being administered.
This patient was assessed as "improved" as a 
result of treatment.
CASE 12
Age 34. Schizophrenia Paranoia. Admitted 2.12.42.
He was simple, childish and emotionally facile. 
He was manneristic, detached, solitary, asocial, 
disinterested, unoccupied and unemployable. He
frequently and openly masturbated. He was incapable
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of sustaining a conversation and his answers to 
questions were often irrelevant. He expressed ill- 
formed, bizarre delusions regarding various females 
who persecuted him physically. He had since 
admission expressed many other fleeting, poorly 
systematised delusions, mainly of persecution and 
of influence. He was untidy and slovenly. He was 
very agitated and depressed with noisy periods. At 
times he was impulsive. He showed no response to ECT.
He was a backward child and was always 
regarded as reserved, peculiar, eccentric and unstable. 
He was a patient in this hospital from 19.6.42. to 
26.8.42. He soon relapsed and had to be re-admitted.
Isoniazid was started on 25.2.53. At first he 
became restless, over-active and impulsive, and he 
went off his food. However, he soon settled, 
becoming quieter, less over-active and no longer 
impulsive. He stopped masturbating, took much more 
interest and was usefully employed in the ward. He 
was tidier and no longer slovenly. He was not 
agitated or depressed. The drug was stopped on 
22.4.53* following which he again became very noisy, 
agitated, impulsive, difficult with his food, and he 
masturbated frequently. Treatment was re-started on
3.6.53. and he quickly improved. He was quiet and
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co-operative, and took his food well. He was clean 
and tidy. He rarely masturbated. He again worked 
in the ward. After ten weeks he began to deteriorate. 
He remained quiet and he ate well, but he resumed his 
frequent masturbation, he became disinterested and 
withdrawn and he was' occasionally incontinent. Rimifon 
was stopped on 25.8.53. Ho appreciable change 
followed.
He gained 3 lbs. in weight while the drug was 
being administered.
This patient was assessed as "improved" with 
treatment as he initially responded well to it.
CASE 13
Age 39* Schizophrenia Hebephrenia. Admitted 30.7.53*
He was suffering from a marked thought disorder 
with thought blocking and auditory hallucinations. He 
said the voices were "An echo of my pent-up thoughts 
such as I like wood and wood often talks to me". His 
conversation was vague, rambling and often irrelevant. 
He was manneristic and he grinned and grimaced at 
times for no apparent reason. He expressed ideas of 
reference and of influence. He was devoid of insight 
and had no appreciation of his position. He showed 
emotional incongruity. He was quiet but not over-co­
operative. He was inclined to be suspicious.
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He joined the Army in 1935. His illness 
began in 1944 when he was admitted to Banstead 
Military Hospital. After several weeks treatment he 
was invalided from the Army. His subsequent work 
record was grossly unstable and he was finally 
unemployed. He stole a small amount of coal and, as 
it was obvious that he could not appreciate right 
from wrong due to his grossly impaired judgment, he 
was admitted to this hospital under the Criminal 
Justice Act.
Isoniazid was started on 27.8.53* and, at the 
same time, a course of ECT. By his sixth convulsion 
on 21.9.53* bis condition had markedly deteriorated. 
His mannerisms and his grinning and grimacing were 
much more frequent and pronounced. He became noisy.
He often laughed aloud and he was continually 
conversing in a loud voice with his hallucinations.
He was slovenly, untidy and unco-operative. ECT was 
stopped and he was continued on isoniazid alone. He 
began to improve. He became amenable and fully co­
operative. His mannerisms diminished and he stopped 
grinning and grimacing. He was quiet and well 
behaved. He denied hallucinations, and he was no 
longer objectively hallucinated. He was clean and 
fairly tidy, and he worked on simple routine jobs in 
the ward under supervision. His thoughts were clearer
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and he conversed more rationally and to the point, 
although, at times, he still rambled and introduced 
irrelevancies and he was incapable of sustaining a 
conversation. He remained falsely elated and rather 
flippant with emotional incongruity. He had very 
little insight, his judgment was grossly impaired and 
he had no proper appreciation of his position. 
Isoniazid was stopped on 30.10.53. and he maintained 
this improvement until 27.11.53* when he was 
transferred to another mental hospital.
He gained 6 lbs. in weight during the 
administration of the drug.
This patient was assessed as "improved" as a 
result of treatment.
CASE 14
Age 36. Schizophrenia Paranoia. Admitted 10.10.46.
For almost two years after admission he had 
expressed various ill-formed delusional ideas, mainly 
of influence and persecution, and his attitude was 
uncertain and suspicious. He was subject to auditory 
hallucinations. He showed only a limited and very 
temporary response to both electro-convulsive and 
insulin coma therapies. For almost four years before 
commencing isoniazid he had been very quiet, with­
drawn, detached, solitary and asocial. He was
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unoccupied and unemployable. He was untidy and 
slovenly. He showed no initiative or spontaneity 
in speech or in action. He was devoid of insight.
He was always of a reserved, unsettled 
disposition. His illness began in 1942 with vague 
delusional beliefs and he. was eventually admitted to 
this hospital on 18.5.43* He was treated with ECT 
but made only a temporary response, and he took his 
discharge on 6.7.43* showing no real improvement.
Shortly after isoniazid was started on 
25.2.53* he became elated, euphoric, manneristic, 
restless and over-active. He frequently interfered 
with and upset other patients. His untidiness 
increased. His conversation was rambling, garrulous 
and often irrelevant. After two weeks he began to 
improve. His conversation became rational and 
coherent. He showed much more initiative and 
spontaneity. He began to take an interest in his 
personal appearance and kept himself clean and tidy. 
His behaviour, however, remained somewhat over-active 
and manneristic. The drug was stopped on 22.4.53* 
following which he became very quiet and withdrawn 
with very limited conversation, and no initiative or 
spontaneity in speech and action. His mannerisms 
disappeared. He continued to keep himself cleaner 
and tidier.
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He gained 6 lbs. in weight while the drug was 
being administered.
This patient was assessed as "improved" as a 
result of treatment.
CASE 15
Age 29. Schizophrenia Paranoia. Admitted 20.12.52.
He was tense, agitated, suspicious and 
apprehensive with delusions of influence and 
persecution. He believed that the wireless was 
controlling him and that someone was disturbing him 
at night by blowing gas up the pipes round his bed, 
and that gas came up through the lavatories. He was 
subject to auditory hallucinations. He was confused 
and retarded, vague and detached. He was solitary 
and unoccupied. He spent his time scribbling on 
scraps of paper. He was devoid of insight and had 
no appreciation of his position. He improved 
considerably with insulin coma therapy but within 
two months he had relapsed. He was given ECT but 
after nine treatments his condition had deteriorated 
and it was stopped.
He was always a reserved and solitary child. 
In 1938 he was a patient in this hospital for nine 
months suffering from a schizophrenic illness which 
responded to cardiazol treatment.
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Isoniazid was started on 27.8.53. and by 
12.10.53* dad produced little change. He was then 
given three treatments of electro-convulsive therapy 
in the ensuing week and, whereas previously he had 
deteriorated with EOT, he now improved rapidly. He 
conversed rationally, coherently and spontaneously.
He was alert and cheerful with no tension, 
retardation or confusion. He kept himself clean and 
tidy. He began to mix with other patients, played 
games and attended social functions. He worked in 
the ward. He was no longer hallucinated and he did 
not express delusional beliefs, although he considered 
that his previous delusions did, in fact, happen. The 
drug was stopped on 21.10.53. and three weeks later he 
began to relapse. By 15.12.53. his condition was 
worse than that on admission. He was tense, agitated, 
disturbed, grossly hallucinated and deluded. He was 
given a further prolonged course of ECT, but this time 
there was no response whatsoever.
He gained 5 lbs. in weight during the 
administration of the drug.
This patient was assessed as "slightly improved" 
as a result of isoniazid treatment.
The above are examples of cases which received
isoniazid. The entire study is summarised in tabulated 
f o r m .









Simplex 3 1 1 4 9
Schizophrenia
Hebephrenia 8 5 4 10 27
Schizophrenia
Catatonia 3 0 0 2 5
Schizophrenia
Paranoia 5 2 1 6 14
Schizophrenia
Undifferentiated 0 0 0 5 5
TOTAL 19 8 6 27 60
TABLE I The response of schizophrenic patients to 
isoniazid.
From Table 1, it will be seen that 19 patients 
(32$) showed a definite improvement with isoniazid 
treatment, and a further 8 patients (13$) improved 
slightly. Case 15 was included under the heading of 
“slightly improved" in view of the fact that he did not 
respond until he had three treatments with EOT. As he 
had previously deteriorated with ECT and, after 
isoniazid was stopped, he relapsed and showed no 
response to ECT, it was held that the drug had played 
some part in his improvement. One case in which ECT
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previous to drug treatment had had no effect 
improved considerably while on isoniazid. When it 
was stopped he relapsed and ECT again had no effect. 
Later he failed to respond to further drug treatment 
but did to ECT in addition to the drug. When either 
was stopped he began to deteriorate, but isoniazid + 
ECT kept him reasonably stable.
The improvement in every case was entirely 
symptomatic. No patient could be considered to have 
made a recovery. Even Case 1 who was discharged was 
only in a state of "partial remission" and the 
prognosis was thought to be poor. The influence of 
the treatment was most seen in its effect on behaviour 
with a stimulation of action.and initiative and flow 
of speech. Many became cleaner and tidier, taking more 
interest in their personal appearance. The improved 
cases took more interest in their surroundings, were 
more inclined to work in the ward, and the quality of 
this work was better. They also became more alert and 
cheerful, and more amenable. In several instances 
aggressive, violent and destructive tendencies were 
relieved. Five patients who had been mute, or almost 
mute, began to speak, three of them quite freely. A 
further seven cases of complete or almost complete 
muteness, on the other hand, showed no response
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whatsoever to the drug. The majority of patients 
who responded showed an amelioration in thought 
disturbances. They became less confused and their 
thoughts were much clearer. Thought blockage 
disappeared. They conversed rationally. Delusions 
were not markedly influenced. In six patients they 
were no longer present after treatment had begun, 
but my impression was that they .were not far removed 
from the surface. Pour patients were no longer 
obviously hallucinated. Several other cases, whilst 
retaining their delusions and hallucinations, were 
less preoccupied with them and their behaviour was 
less dominated by them.
Of the 27 cases who showed some improvement, 
twenty maintained it while isoniazid was being 
administered, almost all relapsing when treatment was 
stopped. Gases 5, 7 and 11 indicate dramatically the 
effect of the drug as they responded well when under 
treatment, relapsed when it was stopped, improved 
when it was restarted, again deteriorated on cessation, 
and for the third time improved when it was re­
commenced.
Six patients became worse while being treated. 
In every case, it was mainly behaviour which was 
affected. They became over-active, manneristic and 
inclined to be aggressive, impulsive, noisy,
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interfering and destructive. One patient became 
confused and bewildered. In each instance, 
improvement set in on stopping isoniazid and all 
returned to the state they were in before receiving 
the drug, although this was sometimes a slow process 
and in three cases took three months.
During the administration of isoniazid, there 
was an average gain in weight of 2.1 lbs. Thirty- 
five patients put on weight, the maximum gain being 
15 lbs. Nine showed no change and the remaining 
patients lost varying amounts of weight up to a 
maximum of 8 lbs. There was no correlation between 
changes in weight and the mental response to the drug.
Venous Blood Sugar (mgms. per 100 ccs.) 
Time in Hours
Fasting 1 2 3
Before treatment 81 87 66 72
After one week 81 94 76 73
After four weeks 82 93 78 76
TABLE II Average Blood Sugar Values before isoniazid 




















A Standard glucose tolerance curve
B Glucose tolerance curve one week 
after commencing isoniazid





0 1 2 
Time in Hours.
FIGURE I Composite glucose tolerance curves showing the 
effect of isoniazid one week and four weeks 
after administration.
From Table II and Figure 1 it is seen that, on 
the average, isoniazid caused a slight rise in the 
blood sugar values at one, two and three hours, 
although having no significant effect on the fasting
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blood sugar. This tends to support the findings of 
Luntz and Smith, although they also claimed that 
isoniazid produces a significant rise in the fasting 
blood sugar.
Number of Oases
Rise Pall Equal Total
(After one week 14 12 3 29Pasting (
(After four weeks 16 11 1 28
(After one week 15 11 3 291 hour (
(After four weeks 18 9 1 28
(After one week 14 13 2 292 hours (
(After four weeks 15 12 1 28
(After one week 14 15 0 293 hours (
(After four weeks 16 11 1 28
TABLE III How individual cases responded in blood 
sugar values one week and four weeks 
after commencing isoniazid as compared 
with their blood sugar values at similar 
times before treatment.
However, Table III shows that out of 29 
patients only 14 had a rise in the fasting blood 
sugar value one week after isoniazid was coiiiiiienced,
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and 16 after four weeks. For the blood sugar values 
one hour after the glucose test dose, isoniazid 
produced an increase in 15 cases and a decrease in 11 
patients. The results for the other times were 
similar. It is therefore considered that these 
findings do not prove that isoniazid has any 
significant effect on the blood sugar values of 
schizophrenic patients.
There was no correlation between changes in 
blood sugar values and mental changes in response to 
the drug.
My findings confirmed the frequent abnormal 
glucose tolerance curves in schizophrenia as reported 
by other workers. Of the 29 curves carried out before 
isoniazid was administered, 14 or 48^ were "flat" 
showing either no rise or an actual fall in the blood 
sugar values one hour after the test dose. Of the 
total of 86 curves done, 37 or 43^ were similarly 
abnormal.
Table IV and Figure II show that, while, on the 
average, there was a general rise in the blood sugar 
curve four days after isoniazid, there was a distinct 
fall after seven days in all values apart from the 
fasting blood sugar. The individual response to the 
drug varied greatly with this group and the results
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were similar to those of Table III. The results
support my previous contention that isoniazid has no
obvious effect on the blood sugar values of
schizophrenic patients. These findings are similar
(19)to those of Keeping and Hutchingsv * for their
group of six non-schizophrenic subjects, and they do










Venous Blood Sugars (mgms.per 100 ccs.) 
Time in Hours





























Average 77 104 105 75 71 72
Four days after isoniazid
Case A 67 86 91 97 71 57
B 158 170 122 83 83 67
C 78 107 128 98 76 69
D 76 170 123 134 118 73
E 66 105 94 42 42 44
P 52 93 87 35 39 64
Average 83 122 106 81 71 62
Seven days after isoniazid
Case A 65 68 65 43 43 42
B 82 84 132 78 76 80
C 65 99 102 73 51 39
D 170 160 148 124 94 88
E 67 67 68 42 54 65
P 72 92 74 52 46 66
Average 88 95 98 69 61 63
TABLE IV Blood sugar values for six patients given a
glucose tolerance test (Exton-Rose technique) 
before isoniazid and again on the fourth and 


























Average glucose tolerance curves
A. Standard glucose tolerance curve
B. Tolerance curve four days after 
isoniazid.
0. Tolerance curve seven days after 
isoniazid.
0 1  i-ir
Time in Hours
FIGURE II Composite glucose tolerance curves for six 
patients A Before isoniazid, B after being 
on the drug for four days, and 0 after 
being on the drug for seven days.
Fasting C.S.F. sugar values 
(mgms. per 100 ccs.)
Before isoniazid After 4 days After 7 days
Case A 50 53 48
B 61 65 68
C 71 55 48
D 60 64 68
E 53 59 37
F 54 52 56
Average 58 60 54
TABLE V Fasting cerebrospinal fluid sugar values 
before isoniazid treatment and again on 
the fourth and seventh days during the 
administration of the drug.
Table V shows the effects of isoniazid on the 
cerebrospinal fluid sugar values. There were no 
significant changes and it was considered that no 
conclusions could be drawn. It would seem, however, 
that isoniazid has no marked or constant effect on 
the cerebrospinal fluid sugar.
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DISCUSSION
My investigations indicate that isoniazid has 
a definite effect on the mental state of schizophrenic 
patients. Of sixty cases, thirty-three patients (557°) 
showed a definite response to the drug, 45$ improving, 
and 10$ deteriorating. The mental changes were 
considerable in all of the patients who deteriorated 
and in nineteen of the cases which improved. In every 
instance the illness was of long standing, the 
majority being of many years duration. It could, 
therefore, have been expected that they would not have 
responded to insulin coma therapy, and, in fact, many 
had had this form of treatment with no lasting benefit. 
The majority had also failed to respond to electro- 
convulsive therapy even as a maintenance symptomatic 
form of treatment. Five patients had been subjected 
to the operation of prefrontal leucotomy with little 
or no benefit, and three of them improved with 
isoniazid treatment.
It is difficult to compare my findings with 
those of insulin coma treatment used in chronic 
schizophrenia as there are few comparable reports in 
the literature. Ellery quotes Muller's results which 
were that, in schizophrenia of over eighteen months'
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duration, there were practically no full remissions 
but 45$ showed improvement.^^ He does not mention 
whether this improvement was maintained. Kalinowsky 
gives similar figures for the effect of EOT in 
schizophrenia of over three years* duration - namely 
no complete recoveries but 50$ were improved.
Hemphill and Walter, reporting on thirty-seven cases 
of schizophrenia lasting more than two years, found 
that two (5$) recovered and thirteen (35$) were 
improved. ̂ T h e s e  results are very similar to those 
I obtained with isoniazid therapy and it is probable 
that, on the average, my cases were of much longer 
duration.
Insulin coma therapy is an impracticable 
measure as a purely ameliorative treatment in chronic 
schizophrenia. The few beds available are needed for 
acute cases, it is time consuming, requires much 
skilled medical and nursing attention, and is not 
without risk. There is therefore, in my opinion, no 
doubt that in chronic schizophrenia isoniazid 
treatment is of very much greater value than insulin 
coma therapy.
EOT is undisputedly of great importance as a 
symptomatic maintenance treatment in long standing 
schizophrenic illnesses. In many cases it can control
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violent, disturbed episodes, alleviate semi-stuporose 
and catatonic states and obviate feeding problems and 
the necessity for prolonged restraint. It is, of 
course, a simple treatment to administer. I have no 
doubt that, from a wide viewpoint, EOT is a much more 
powerful therapeutic weapon in chronic schizophrenia 
than isoniazid. On the other hand, as I remarked 
previously, the majority of the patients in my study 
had failed to respond to EOT and yet 45$ of them 
improved with isoniazid. I consider that the drug 
had more effect than EOT in stimulating interest and 
initiative, and in making the patients more sociable.
Isoniazid cannot be considered to be the 
answer to the treatment for this distressing illness 
but, in the present state of our lack of knowledge, 
it does seem that it might have a place as a symptom­
atic measure in the chronic stages especially if EOT 
fails. It is a simple, safe remedy, which requires 
no supervision apart from seeing that the tablets are 
swallowed. The toxicity of the drug is extremely low 
and none of my patients showed any evidence of 
toxicity when on it. The dose I used, 400 mgms. daily, 
is considered to be towards the upper margin of a safe 
dose, but I feel it would be worth studying the 
effects of larger doses. An illness of such severity
- 110 -
as schizophrenia justifies the taking of some 
reasonable risks in treatment, and pharmocological 
studies of isoniazid have proved that any toxic 
changes are in all probability reversible, disappear­
ing when the drug is stopped. From my investigations,
I would say that a dose of 400 mgms. daily could 
safely be continued in most cases for prolonged 
periods, if not indefinitely.
As the results with isoniazid were approximately 
the same as those with EOT and insulin coma in the 
treatment of chronic schizophrenia, I consider that 
isoniazid is worth a trial in the early stages of the 
illness.
I mentioned previously two patients who had 
failed to respond to EOT and who showed no marked 
change with isoniazid but improved with ECT + the drug. 
Two further cases gave a similar resj)onse. This 
suggests a field for further study as to whether 
isoniazid might possibly augment the therapeutic 
action of ECT and even of insulin coma treatment.
Isoniazid is, as with the other forms of 
treatment in schizophrenia, an empirical method and 
therefore a discussion on its possible mode of action 
will have to be entirely theoretical.
The fact that my findings showed that isoniazid 
does not produce any significant rise in the blood
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sugar levels of schizophrenic patients does not 
disprove the investigations of Luntz and Smith who 
claimed that the drug causes a temporary elevation 
of the blood sugar level, and makes both the rise 
and fall of an oral glucose tolerance test slower
(21)in diabetic patients and in non-diabetic controls.v 1
Many workers have reported on the frequency of
abnormal responses to the glucose tolerance test in
schizophrenia and my own results confirmed this.
However, Luntz and Smith claimed a considerable rise
in the fasting blood sugar with isoniazid while I
found no marked change, and it is generally held that
the fasting blood sugar of schizophrenic patients is
within normal limits. This, and the report of
(IQ)Keeping and Hutchings'* on the effect of isoniazid 
on glucose tolerance tests in a small series of cases, 
would tend to throw doubt on the claims of Luntz and 
Smith. It would seem that, if isoniazid exerts its 
effect on the mental state of schizophrenia by 
disturbing the carbohydrate metabolism, it does so in 
a more subtle way than by merely raising the blood 
sugar level.
Isoniazid, in toxic doses in animals, has been 
found to be a central nervous system stimulant. Acute 
toxicity in mice and dogs is characterized by 
excitement and convulsions which were delayed in onset
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even after intravenous administration. Chronic 
administration to dogs resulted in anorexia, loss 
in "body weight, ataxia, and tonic and clonic 
convulsions.^^ In man appreciable concentrations 
of the drug have been demonstrated in the eerebro-
(5)spinal fluid within three hours after oral intake* ' 
Selikoff has reported certain side effects 
occasionally occurring during the early weeks of 
treatment with isoniazid. They are vertigo, insomnia, 
constipation or difficulty in micturition which he 
suggests may be of autonomic origin and twitchings of 
the lower extremities and increased reflexes, which 
he considers point to an action of the drug on the 
central nervous system. It is therefore possible
that isoniazid acts in schizophrenia by a direct 
stimulation of the autonomic or central nervous 
systems, or both. In this connection, it must be 
remembered the widely held view that insulin coma and 
electro-convulsive therapies produce their effect by 
influencing diencephalic mechanisms.
Isoniazid in sufficient dosage is a convulsant 
drug. Wortis states that most known convulsants, 
including ECT and insulin hypoglycaemia, promote 
acetylcholine production and he suggests that they 
probably effect a redistribution of brain acetyl­
choline . (46)
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Isonicotinic acid hydrazide is closely allied 
chemically to nicotinic acid and nicotinamide as is 









Hoskins' uncompleted studies point towards rather
marked deficits in the tissue vitamin stores in
schizophrenia, and he underlines the important role
played by the vitamins in the enzyme systems of the 
(13)body.v ^1 Nicotinic acid and its amide are both 
thought to function physiologically by forming part 
of the molecular structure of several complex enzymes 
which act as hydrogen carriers in biological processes. 
The vitamin probably takes part in the metabolism of 
carbohydrate and it is essential for the normal 
functioning of the nervous system. The mental 
symptoms of pellagra are due to a deficiency of 
nicotinic acid with probably an additional deficiency 
of other members of the vitamin B-complex. I 
indicated earlier my opinion that schizophrenia may 
be caused by a defect in cerebral metabolism due to
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a fault in one or more of the enzyme systems. I
suggest that isoniazid, which is closely related to
a known enzyme constituent, exerts its effect on the
mental state of schizophrenia by replacing one of
the missing or faulty constituents of the cerebral
enzyme systems, thereby bringing cerebral metabolism
closer to normal.
McConnell and Cheetham report one case of
acute pellagra occurring in the course of isoniazid
(2 2 )therapy. ' Pegum has suggested that isoniazid may
block the action of nicotinamide by competitive 
(31)inhibition.w  ' Zabad also reports a case of mental 
symptoms developing in a patient on isoniazid who 
was immediately cured by stopping the drug and 
administering nicotinamide. ) Both of these cases
appear likely to have had a latent nicotinic acid 
deficiency before treatment. This pellagra-type of 
toxicity with isoniazid must be very rare as no 
mention of it is made in the reports to the Medical 
Research Council. McConnell and Cheetham remark that 
the amount of isoniazid which would compete success­
fully with nicotinamide in the formation of co-enzymes 
depends, by the law of mass equilibrium, on their 
relative concentration and their relative affinity for 
the co-enzyme residue and that, as no previous case of
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fully developed pellagra had "been reported during
isoniazid therapy, its affinity is probably not
great and its pellagra-producing effect depends on
the patient's original nicotinamide level being
(22)low. I agree with their remarks. In my series
of schizophrenic cases, if isoniazid invariably
disturbed the cerebral metabolism by blocking the %
action of nicotinamide thereby depriving the patient 
of this essential vitamin, one would have expected 
the majority of my cases to have deteriorated 
mentally, instead of which 45i° actually improved.
On the other hand this mechanism could explain the 
reason why six of my cases deteriorated. An incipent 
vitamin deficiency is always a possibility in the 
chronic population of a mental hospital. It is noted 
that five of these six patients lost small amounts of 
weight of from 3 to 5 lbs. and the group showed an 
average loss of 2.7 lbs. while under treatment as 
compared with the average gain of 2.1 lbs. for the 
whole series. In further investigations with the drug, 
it would therefore be advisable to combine its 
administration with that of nicotinamide.
I consider that the fact that schizophrenia is 
influenced by this drug is a further support for the 
view that the illness is due to an organic cause and 




An account of the discovery and progress of 
insulin coma and the convulsive therapies is given.
The symptomatology of schizophrenia is described and 
a review is made of the various theories of aetiology.
The technique of insulin coma treatment and of 
cardiazol and electric convulsive therapies is 
presented in detail. The results of these treatments 
are given and a discussion is made on the selection 
of cases. The theories suggested as to their mode of 
action are discussed.
An account is given of the pharmocology and 
therapeutics of isonicotinic acid hydrazide 
(isoniazid). It has been suggested that this drug 
produces a temporary elevation of the blood sugar level 
and causes a disturbance in carbohydrate metabolism. 
Sixty patients suffering from schizophrenia of many 
years' duration were treated with isoniazid 
administered for varying periods in an oral dosage of 
100 mgms. four times daily. 32$ showed a definite 
improvement, a further 13$ improved slightly, while 
10$ deteriorated. In the remaining 45$, the drug 
produced no significant mental change.
In twenty-nine cases, blood sugar estimations 
were carried out in the fasting condition and one,
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two and three hours after the ingestion of 100 Gm. 
of glucose. This was done before commencing 
isoniazid therapy, and one and three weeks later.
In six cases, blood sugar estimations were carried 
out in the fasting condition and then at half hourly 
intervals to two and a half hours after the ingestion 
of 100 Gm. of glucose in divided doses by the Exton- 
Rose technique. This v/as done before isoniazid was 
started, and again four and seven days later. On 
these days the fasting cerebrospinal fluid sugar 
estimations were also done.
The results of isoniazid in the treatment of 
schizophrenia are discussed and compared with those 
for insulin coma and electro-convulsive treatments. 
Further possible uses for the drug in the treatment 
of mental illness are suggested. Theories as to its 
mode of action are discussed.
CONCLUSIONS
1. Isoniazid has a definite effect on the mental 
state of schizophrenic patients and the results 
of this treatment in chronic schizophrenia 
compare favourably with those of insulin coma and 
electro-convulsive therapies.
2. IViy findings also suggest that isoniazid might
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possibly augment the therapeutic effects of ECT.
3* The investigation confirms the frequent abnormal 
responses to the glucose tolerance test in 
schizophrenia as reported by other workers.
4. The results do not support the contention that 
isoniazid produces a temporary elevation of the 
blood sugar level and causes a disturbance in 
carbohydrate metabolism.
5. Isoniazid is closely related pharmacologically 
to nicotinic acid and nicotinamide, and it is 
suggested that it acts in schizophrenia by 
influencing the enzyme systems concerned in 
cerebral metabolism.
6. While no evidence of toxicity was noted in this 
series of cases, it is recommended that, in 
future, nicotinic acid be administered with 
isoniazid.
7. The fact that the drug does have an effect on 
the mental state of schizophrenia is considered 
to be a further support for an organic aetiology 
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